{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:58:42Z","timestamp":1775195922589,"version":"3.50.1"},"reference-count":428,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:00:00Z","timestamp":1247184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:00:00Z","timestamp":1247184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s12016-009-8155-9","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T13:07:00Z","timestamp":1247144820000},"page":"201-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Evidence for the Use of Intravenous Immunoglobulins\u2014A Review of the Literature"],"prefix":"10.1007","volume":"38","author":[{"given":"Shaye","family":"Kivity","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uriel","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udi","family":"Nussinovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neophytos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,10]]},"reference":[{"key":"8155_CR1","first-page":"81","volume":"36","author":"P Imbach","year":"1981","unstructured":"Imbach P, Barandun S, Baumgartner C, Hirt A, Hofer F, Wagner HP (1981) High-dose intravenous gamma globulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood. Helv Paediatr Acta 36:81\u201386","journal-title":"Helv Paediatr Acta"},{"key":"8155_CR2","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1161\/hc4901.102568","volume":"104","author":"SA Hunt","year":"2001","unstructured":"Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr (2001) ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 104:2996\u20133007","journal-title":"Circulation"},{"key":"8155_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1191\/0961203303lu2168rr","volume":"14","author":"U Katz","year":"2005","unstructured":"Katz U, Shoenfeld Y (2005) Review: intravenous immunoglobulin therapy and thromboembolic complications. Lupus 14:802\u2013808","journal-title":"Lupus"},{"key":"8155_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","volume":"29","author":"H Orbach","year":"2005","unstructured":"Orbach H, Katz U, Sherer Y, Shoenfeld Y (2005) Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol 29:173\u2013184","journal-title":"Clin Rev Allergy Immunol"},{"key":"8155_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","volume":"34","author":"H Orbach","year":"2004","unstructured":"Orbach H, Tishler M, Shoenfeld Y (2004) Intravenous immunoglobulin and the kidney\u2014a two-edged sword. Semin Arthritis Rheum 34:593\u2013601","journal-title":"Semin Arthritis Rheum"},{"key":"8155_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","volume":"84","author":"AB Federici","year":"2000","unstructured":"Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE (2000) Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 84:345\u2013349","journal-title":"Thromb Haemost"},{"key":"8155_CR7","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","volume":"92","author":"AB Federici","year":"1998","unstructured":"Federici AB, Stabile F, Castaman G, Canciani MT, Mannucci PM (1998) Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 92:2707\u20132711","journal-title":"Blood"},{"key":"8155_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJM199201233260413","volume":"326","author":"E Ben-Chetrit","year":"1992","unstructured":"Ben-Chetrit E, Putterman C (1992) Transient neutropenia induced by intravenous immune globulin. N Engl J Med 326:270\u2013271","journal-title":"N Engl J Med"},{"key":"8155_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000089465","volume":"115","author":"MS El Alfy","year":"2006","unstructured":"El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS (2006) Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. Acta Haematol 115:46\u201352","journal-title":"Acta Haematol"},{"key":"8155_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jpeds.2005.11.019","volume":"148","author":"MD Tarantino","year":"2006","unstructured":"Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ (2006) Single dose of anti-D immune globulin at 75 microg\/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 148:489\u2013494","journal-title":"J Pediatr"},{"key":"8155_CR11","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/hc3801.096353","volume":"104","author":"P Aukrust","year":"2001","unstructured":"Aukrust P, Gullestad L, Lappegard KT, Ueland T, Aass H, Wikeby L, Simonsen S, Froland SS, Mollnes TE (2001) Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment. Circulation 104:1494\u20131500","journal-title":"Circulation"},{"key":"8155_CR12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","volume":"103","author":"DM McNamara","year":"2001","unstructured":"McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103:2254\u20132259","journal-title":"Circulation"},{"key":"8155_CR13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.103.2.220","volume":"103","author":"L Gullestad","year":"2001","unstructured":"Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Froland SS, Aukrust P (2001) Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103:220\u2013225","journal-title":"Circulation"},{"key":"8155_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00380-006-0923-3","volume":"22","author":"S Kato","year":"2007","unstructured":"Kato S, Morimoto S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, Miyagishima K, Mori N, Hishida H (2007) Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis. Heart Vessels 22:48\u201351","journal-title":"Heart Vessels"},{"key":"8155_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00000441-200312000-00013","volume":"326","author":"GA Stouffer","year":"2003","unstructured":"Stouffer GA, Sheahan RG, Lenihan DJ, Patel P, Lenihan DJ (2003) The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin. Am J Med Sci 326:369\u2013374","journal-title":"Am J Med Sci"},{"key":"8155_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.hrtlng.2004.12.003","volume":"34","author":"H Ozdogu","year":"2005","unstructured":"Ozdogu H, Boga C (2005) Fatal cardiac tamponade in a patient with Kawasaki disease. Heart Lung 34:257\u2013259","journal-title":"Heart Lung"},{"key":"8155_CR17","first-page":"233","volume":"101","author":"DM Hunsaker","year":"2003","unstructured":"Hunsaker DM, Hunsaker JC 3rd, Adams KC, Noonan JA, Ackermann DM (2003) Fatal Kawasaki disease due to coronary aneurysm rupture with massive cardiac tamponade. J Ky Med Assoc 101:233\u2013238","journal-title":"J Ky Med Assoc"},{"key":"8155_CR18","first-page":"312","volume":"49","author":"A Soncagi","year":"2007","unstructured":"Soncagi A, Devrim I, Karagoz T, Dilber E, Celiker A, Ozen S, Secmeer G (2007) Septated pericarditis associated with Kawasaki disease: a brief case report. Turk J Pediatr 49:312\u2013314","journal-title":"Turk J Pediatr"},{"key":"8155_CR19","first-page":"55","volume":"10","author":"Y Sherer","year":"2008","unstructured":"Sherer Y, Kuechler S, Jose Scali J, Rovensky J, Levy Y, Zandman-Goddard G, Shoenfeld Y (2008) Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases. Isr Med Assoc J 10:55\u201357","journal-title":"Isr Med Assoc J"},{"key":"8155_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10067-004-0959-7","volume":"24","author":"D Peterlana","year":"2005","unstructured":"Peterlana D, Puccetti A, Simeoni S, Tinazzi E, Corrocher R, Lunardi C (2005) Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases. Clin Rheumatol 24:18\u201321","journal-title":"Clin Rheumatol"},{"key":"8155_CR21","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.10905","volume":"95","author":"S Shapiro","year":"2002","unstructured":"Shapiro S, Shoenfeld Y, Gilburd B, Sobel E, Lahat N (2002) Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages. Cancer 95:2032\u20132037","journal-title":"Cancer"},{"key":"8155_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1385\/CRIAI:29:3:311","volume":"29","author":"E Matsuura","year":"2005","unstructured":"Matsuura E, Kobayashi K, Inoue K, Shoenfeld Y (2005) Intravenous immunoglobulin and atherosclerosis. Clin Rev Allergy Immunol 29:311\u2013319","journal-title":"Clin Rev Allergy Immunol"},{"key":"8155_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00128072-200103090-00003","volume":"3","author":"RV Williams","year":"2001","unstructured":"Williams RV, Minich LL, Tani LY (2001) Pharmacological therapy for patients with Kawasaki disease. Paediatr Drugs 3:649\u2013660","journal-title":"Paediatr Drugs"},{"key":"8155_CR24","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708\u20131733","journal-title":"Pediatrics"},{"issue":"940\u2013944","key":"8155_CR25","first-page":"998","volume":"146","author":"U Nussinovitch","year":"2007","unstructured":"Nussinovitch U, Shoenfeld Y (2007) Neonatal lupus erythematosus\u2014cardiac manifestations and atrio-ventricular conduction block. Harefuah 146(940\u2013944):998","journal-title":"Harefuah"},{"key":"8155_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.10716","volume":"48","author":"R Kaaja","year":"2003","unstructured":"Kaaja R, Julkunen H (2003) Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum 48:280\u2013281 author reply 281\u2013282","journal-title":"Arthritis Rheum"},{"key":"8155_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","volume":"111","author":"E Letko","year":"2004","unstructured":"Letko E, Miserocchi E, Daoud YJ, Christen W, Foster CS, Ahmed AR (2004) A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol 111:303\u2013310","journal-title":"Clin Immunol"},{"key":"8155_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","volume":"111","author":"N Sami","year":"2004","unstructured":"Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR (2004) Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up. Ophthalmology 111:1380\u20131382","journal-title":"Ophthalmology"},{"key":"8155_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/0927-3948(200003)811-SFT049","volume":"8","author":"P LeHoang","year":"2000","unstructured":"LeHoang P, Cassoux N, George F, Kullmann N, Kazatchkine MD (2000) Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy. Ocul Immunol Inflamm 8:49\u201357","journal-title":"Ocul Immunol Inflamm"},{"key":"8155_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/166.1.38","volume":"166","author":"RJ Hamill","year":"1992","unstructured":"Hamill RJ, Musher DM, Groover JE, Zavell PJ, Watson DA (1992) IgG antibody reactive with five serotypes of Streptococcus pneumoniae in commercial intravenous immunoglobulin preparations. J Infect Dis 166:38\u201342","journal-title":"J Infect Dis"},{"key":"8155_CR31","first-page":"114","volume":"39","author":"Z Pourpak","year":"2006","unstructured":"Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, Chavoshzadeh Z, Jadid L, Rezaei N, Moin M (2006) Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 39:114\u2013120","journal-title":"J Microbiol Immunol Infect"},{"key":"8155_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1398-9995.2005.00756.x","volume":"60","author":"O Favre","year":"2005","unstructured":"Favre O, Leimgruber A, Nicole A, Spertini F (2005) Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency. Allergy 60:385\u2013390","journal-title":"Allergy"},{"key":"8155_CR33","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1056\/NEJM200012073432307","volume":"343","author":"JA Lekstrom-Himes","year":"2000","unstructured":"Lekstrom-Himes JA, Gallin JI (2000) Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 343:1703\u20131714","journal-title":"N Engl J Med"},{"key":"8155_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","volume":"6","author":"U Katz","year":"2007","unstructured":"Katz U, Achiron A, Sherer Y, Shoenfeld Y (2007) Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 6:257\u2013259","journal-title":"Autoimmun Rev"},{"key":"8155_CR35","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/bmj.313.7069.1400","volume":"313","author":"S Misbah","year":"1996","unstructured":"Misbah S (1996) Intravenous immunoglobulin in the Guillain\u2013Barr\u00e9 syndrome. Products with low IgA content may be used in patients with total IgA deficiency. BMJ 313:1400","journal-title":"BMJ"},{"key":"8155_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1191\/096120399678841007","volume":"8","author":"Y Levy","year":"1999","unstructured":"Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y (1999) A study of 20 SLE patients with intravenous immunoglobulin\u2014clinical and serologic response. Lupus 8:705\u2013712","journal-title":"Lupus"},{"key":"8155_CR37","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/rheumatology\/39.11.1301","volume":"39","author":"M Hundt","year":"2000","unstructured":"Hundt M, Manger K, Dorner T, Grimbacher B, Kalden P, Rascu A, Weber D, Burmester GR, Peter HH, Kalden JR, Schmidt RE (2000) Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin. Rheumatology (Oxford) 39:1301\u20131302","journal-title":"Rheumatology (Oxford)"},{"key":"8155_CR38","first-page":"71","volume":"23","author":"JO Schroeder","year":"1996","unstructured":"Schroeder JO, Zeuner RA, Euler HH, Loffler H (1996) High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study. J Rheumatol 23:71\u201375","journal-title":"J Rheumatol"},{"key":"8155_CR39","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/ard.2006.058784","volume":"66","author":"D Micheloud","year":"2007","unstructured":"Micheloud D, Calderon M, Caparrros M, D'Cruz DP (2007) Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis 66:986\u2013987","journal-title":"Ann Rheum Dis"},{"key":"8155_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s100670050091","volume":"18","author":"Y Sherer","year":"1999","unstructured":"Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238\u2013240","journal-title":"Clin Rheumatol"},{"key":"8155_CR41","first-page":"75","volume":"29","author":"C Arnal","year":"2002","unstructured":"Arnal C, Piette JC, Leone J, Taillan B, Hachulla E, Roudot-Thoraval F, Papo T, Schaeffer A, Bierling P, Godeau B (2002) Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 29:75\u201383","journal-title":"J Rheumatol"},{"key":"8155_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09546630310018789","volume":"15","author":"M Goodfield","year":"2004","unstructured":"Goodfield M, Davison K, Bowden K (2004) Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE). J Dermatolog Treat 15:46\u201350","journal-title":"J Dermatolog Treat"},{"key":"8155_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/096120339700600414","volume":"6","author":"O De Pita","year":"1997","unstructured":"De Pita O, Bellucci AM, Ruffelli M, Girardelli CR, Puddu P (1997) Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus. Lupus 6:415\u2013417","journal-title":"Lupus"},{"key":"8155_CR44","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10067-006-0222-5","volume":"26","author":"CE Lampropoulos","year":"2007","unstructured":"Lampropoulos CE, Hughes GR, DC DP (2007) Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative. Clin Rheumatol 26:981\u2013983","journal-title":"Clin Rheumatol"},{"key":"8155_CR45","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/archderm.135.9.1124","volume":"135","author":"T Genereau","year":"1999","unstructured":"Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135:1124\u20131125","journal-title":"Arch Dermatol"},{"key":"8155_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1385\/CRIAI:29:3:219","volume":"29","author":"G Zandman-Goddard","year":"2005","unstructured":"Zandman-Goddard G, Levy Y, Shoenfeld Y (2005) Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol 29:219\u2013228","journal-title":"Clin Rev Allergy Immunol"},{"key":"8155_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/rheumatology\/kei074","volume":"45","author":"M Noursadeghi","year":"2006","unstructured":"Noursadeghi M, Aqel N, Gibson P, Pasvol G (2006) Successful treatment of severe Kikuchi's disease with intravenous immunoglobulin. Rheumatology (Oxford) 45:235\u2013237","journal-title":"Rheumatology (Oxford)"},{"key":"8155_CR48","first-page":"998","volume":"85","author":"JS Chen","year":"2000","unstructured":"Chen JS, Chang KC, Cheng CN, Tsai WH, Su IJ (2000) Childhood hemophagocytic syndrome associated with Kikuchi's disease. Haematologica 85:998\u20131000","journal-title":"Haematologica"},{"issue":"Suppl 4","key":"8155_CR49","doi-asserted-by":"publisher","first-page":"419s","DOI":"10.1016\/S0248-8663(00)88672-5","volume":"20","author":"S Vignes","year":"1999","unstructured":"Vignes S, Wechsler B (1999) Still's disease in adults: treatment with intravenous immunoglobulins. Rev Med Interne 20(Suppl 4):419s\u2013422s","journal-title":"Rev Med Interne"},{"key":"8155_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","volume":"16","author":"S Permal","year":"1995","unstructured":"Permal S, Wechsler B, Cabane J, Perrot S, Blum L, Imbert JC (1995) Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Interne 16:250\u2013254","journal-title":"Rev Med Interne"},{"key":"8155_CR51","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/rheumatology\/38.10.1024","volume":"38","author":"E Liozon","year":"1999","unstructured":"Liozon E, Ly K, Aubard Y, Vidal E (1999) Intravenous immunoglobulins for adult Still's disease and pregnancy. Rheumatology (Oxford) 38:1024\u20131025","journal-title":"Rheumatology (Oxford)"},{"key":"8155_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DR Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood CM (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433\u2013439","journal-title":"QJM"},{"key":"8155_CR53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/978-1-4757-9182-2_84","volume":"336","author":"DR Jayne","year":"1993","unstructured":"Jayne DR, Lockwood CM (1993) Pooled intravenous immunoglobulin in the management of systemic vasculitis. Adv Exp Med Biol 336:469\u2013472","journal-title":"Adv Exp Med Biol"},{"key":"8155_CR54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.1995.tb02268.x","volume":"101","author":"C Richter","year":"1995","unstructured":"Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E, Gross WL (1995) Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 101:2\u20137","journal-title":"Clin Exp Immunol"},{"key":"8155_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000024199","volume":"119","author":"Y Levy","year":"1999","unstructured":"Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y, Fabbrizzi F, Terryberry J, Peter J, Shoenfeld Y (1999) Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 119:231\u2013238","journal-title":"Int Arch Allergy Immunol"},{"key":"8155_CR56","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/rheumatology\/35.11.1150","volume":"35","author":"DR Jayne","year":"1996","unstructured":"Jayne DR, Lockwood CM (1996) Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol 35:1150\u20131153","journal-title":"Br J Rheumatol"},{"key":"8155_CR57","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.7883\/yoken.JJID.2004.17","volume":"57","author":"E Muso","year":"2004","unstructured":"Muso E, Ito-Ihara T, Ono T, Imai E, Yamagata K, Akamatsu A, Suzuki K (2004) Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan. Jpn J Infect Dis 57:S17\u2013S18","journal-title":"Jpn J Infect Dis"},{"key":"8155_CR58","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1136\/ard.2003.015453","volume":"63","author":"MG Danieli","year":"2004","unstructured":"Danieli MG, Cappelli M, Malcangi G, Logullo F, Salvi A, Danieli G (2004) Long term effectiveness of intravenous immunoglobulin in Churg\u2013Strauss syndrome. Ann Rheum Dis 63:1649\u20131654","journal-title":"Ann Rheum Dis"},{"key":"8155_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1081-1206(10)61714-0","volume":"92","author":"N Tsurikisawa","year":"2004","unstructured":"Tsurikisawa N, Taniguchi M, Saito H, Himeno H, Ishibashi A, Suzuki S, Akiyama K (2004) Treatment of Churg\u2013Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol 92:80\u201387","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8155_CR60","first-page":"13","volume":"10","author":"F Carmassi","year":"1992","unstructured":"Carmassi F, Morale M, Puccetti R, Pistelli F, Palla R, Bevilacqua G, Viacava P, Antonelli A, Mariani G (1992) Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis. Clin Exp Rheumatol 10:13\u201317","journal-title":"Clin Exp Rheumatol"},{"key":"8155_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/00063030-200418010-00006","volume":"18","author":"M Malaguarnera","year":"2004","unstructured":"Malaguarnera M, Guccione N, Musumeci S, Brogna A, Motta M, Di Fazio I (2004) Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C. BioDrugs 18:63\u201370","journal-title":"BioDrugs"},{"key":"8155_CR62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-120-6-199403150-00005","volume":"120","author":"G Rostoker","year":"1994","unstructured":"Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, Andre C, Adnot S, Bonin P, Bierling P, Remy P, Lagrue G, Lang P, Weil B (1994) High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch\u2013Sch\u00f6nlein purpura. Ann Intern Med 120:476\u2013484","journal-title":"Ann Intern Med"},{"key":"8155_CR63","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1651-2227.2001.tb01370.x","volume":"90","author":"T Lamireau","year":"2001","unstructured":"Lamireau T, Rebouissoux L, Hehunstre JP (2001) Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch\u2013Sch\u00f6nlein purpura. Acta Paediatr 90:1081\u20131082","journal-title":"Acta Paediatr"},{"key":"8155_CR64","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2169\/internalmedicine.38.376","volume":"38","author":"A Kusuda","year":"1999","unstructured":"Kusuda A, Migita K, Tsuboi M, Degawa M, Matsuoka N, Tominaga M, Kawakami A, Kawabe Y, Taguchi T, Eguchi K (1999) Successful treatment of adult-onset Henoch\u2013Sch\u00f6nlein purpura nephritis with high-dose immunoglobulins. Intern Med 38:376\u2013379","journal-title":"Intern Med"},{"key":"8155_CR65","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/ndt\/14.3.795b","volume":"14","author":"IR Villarreal","year":"1999","unstructured":"Villarreal IR, Ortega O, Vigil A, Gallar P, Oliet A, Garcia-Rubiales A, Jimenez E (1999) Henoch\u2013Sch\u00f6nlein nephritis. Adverse effect of treatment with intravenous immunoglobulin. Nephrol Dial Transplant 14:795\u2013797","journal-title":"Nephrol Dial Transplant"},{"key":"8155_CR66","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.7326\/0003-4819-125-12-199612150-00030","volume":"125","author":"MA Hamidou","year":"1996","unstructured":"Hamidou MA, Pottier MA, Dupas B (1996) Intravenous immunoglobulin in Henoch\u2013Sch\u00f6nlein purpura. Ann Intern Med 125:1013\u20131014","journal-title":"Ann Intern Med"},{"key":"8155_CR67","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2169\/internalmedicine.42.910","volume":"42","author":"M Matsuda","year":"2003","unstructured":"Matsuda M, Miki J, Oguchi K, Tabata K, Ikeda S (2003) Fasciitis in mixed connective tissue disease successfully treated with high-dose intravenous immunoglobulin. Intern Med 42:910\u2013911","journal-title":"Intern Med"},{"key":"8155_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1067\/mjd.2001.118539","volume":"46","author":"A Ulmer","year":"2002","unstructured":"Ulmer A, Kotter I, Pfaff A, Fierlbeck G (2002) Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease. J Am Acad Dermatol 46:123\u2013127","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR69","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/art.20195","volume":"50","author":"Y Levy","year":"2004","unstructured":"Levy Y, Amital H, Langevitz P, Nacci F, Righi A, Conforti L, Generini S, Matucci Cerinic M, Shoenfeld Y (2004) Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. Arthritis Rheum 50:1005\u20131007","journal-title":"Arthritis Rheum"},{"key":"8155_CR70","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1365-2133.2007.07777.x","volume":"156","author":"H Ihn","year":"2007","unstructured":"Ihn H, Mimura Y, Yazawa N, Jinnin M, Asano Y, Yamane K, Tamaki K (2007) High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma. Br J Dermatol 156:1058\u20131060","journal-title":"Br J Dermatol"},{"key":"8155_CR71","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/ard.2006.060111","volume":"66","author":"F Nacci","year":"2007","unstructured":"Nacci F, Righi A, Conforti ML, Miniati I, Fiori G, Martinovic D, Melchiorre D, Sapir T, Blank M, Shoenfeld Y, Pignone AM, Cerinic MM (2007) Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. Ann Rheum Dis 66:977\u2013979","journal-title":"Ann Rheum Dis"},{"key":"8155_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s100670050158","volume":"19","author":"Y Levy","year":"2000","unstructured":"Levy Y, Sherer Y, Langevitz P, Lorber M, Rotman P, Fabrizzi F, Shoenfeld Y (2000) Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin\u2014a preliminary report. Clin Rheumatol 19:207\u2013211","journal-title":"Clin Rheumatol"},{"key":"8155_CR73","first-page":"919","volume":"23","author":"EH Giannini","year":"1996","unstructured":"Giannini EH, Lovell DJ, Silverman ED, Sundel RP, Tague BL, Ruperto N (1996) Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I\/II study. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 23:919\u2013924","journal-title":"J Rheumatol"},{"key":"8155_CR74","first-page":"117","volume":"40","author":"J Oppermann","year":"1994","unstructured":"Oppermann J, Mobius D (1994) Therapeutical and immunological effects of methylprednisolone pulse therapy in comparison with intravenous immunoglobulin. Treatment in patients with juvenile chronic arthritis. Acta Univ Carol Med (Praha) 40:117\u2013121","journal-title":"Acta Univ Carol Med (Praha)"},{"key":"8155_CR75","first-page":"910","volume":"23","author":"Y Uziel","year":"1996","unstructured":"Uziel Y, Laxer RM, Schneider R, Silverman ED (1996) Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a follow-up study. J Rheumatol 23:910\u2013918","journal-title":"J Rheumatol"},{"key":"8155_CR76","first-page":"603","volume":"8","author":"AM Prieur","year":"1990","unstructured":"Prieur AM, Adleff A, Debre M, Boulate P, Griscelli C (1990) High dose immunoglobulin therapy in severe juvenile chronic arthritis: long-term follow-up in 16 patients. Clin Exp Rheumatol 8:603\u2013608","journal-title":"Clin Exp Rheumatol"},{"key":"8155_CR77","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/art.1780390621","volume":"39","author":"KS Kanik","year":"1996","unstructured":"Kanik KS, Yarboro CH, Naparstek Y, Plotz PH, Wilder RL (1996) Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis. Arthritis Rheum 39:1027\u20131029","journal-title":"Arthritis Rheum"},{"key":"8155_CR78","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF01892896","volume":"67","author":"H Becker","year":"1989","unstructured":"Becker H, Mitropoulou G, Helmke K (1989) Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin. Klin Wochenschr 67:286\u2013290","journal-title":"Klin Wochenschr"},{"key":"8155_CR79","first-page":"657","volume":"14","author":"WP Maksymowych","year":"1996","unstructured":"Maksymowych WP, Avina-Zubieta A, Luong M, Russell AS (1996) High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy. Clin Exp Rheumatol 14:657\u2013660","journal-title":"Clin Exp Rheumatol"},{"key":"8155_CR80","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/rheumatology\/40.8.955","volume":"40","author":"H Maeda","year":"2001","unstructured":"Maeda H, Furonaka O, Matsushima K, Awaya Y, Kuwabara M (2001) Successful treatment of \u2018malignant rheumatoid arthritis\u2019 in Japan with pooled intravenous immunoglobulin. Rheumatology (Oxford) 40:955\u2013956","journal-title":"Rheumatology (Oxford)"},{"key":"8155_CR81","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","volume":"60","author":"Y Takahashi","year":"2003","unstructured":"Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I (2003) Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sj\u00f6gren\u2019s syndrome. IV immunoglobulin. Neurology 60:503\u2013505","journal-title":"Neurology"},{"key":"8155_CR82","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.2005.084533","volume":"77","author":"M Kizawa","year":"2006","unstructured":"Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G (2006) Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sj\u00f6gren\u2019s syndrome. J Neurol Neurosurg Psychiatry 77:967\u2013969","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR83","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/jnnp.60.6.699","volume":"60","author":"JA Molina","year":"1996","unstructured":"Molina JA, Benito-Leon J, Bermejo F, Jimenez-Jimenez FJ, Olivan J (1996) Intravenous immunoglobulin therapy in sensory neuropathy associated with Sj\u00f6gren\u2019s syndrome. J Neurol Neurosurg Psychiatry 60:699","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR84","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000","journal-title":"N Engl J Med"},{"key":"8155_CR85","first-page":"322","volume":"98","author":"MG Danieli","year":"2007","unstructured":"Danieli MG, Calcabrini L, Marchetti A, Calabrese V, Pettinari L, Massaccesi C, Gabrielli A, Danieli G (2007) Intravenous immunoglobulin treatment in autoimmune diseases. Recenti Prog Med 98:322\u2013326","journal-title":"Recenti Prog Med"},{"key":"8155_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10165-007-0013-0","volume":"18","author":"E Saito","year":"2008","unstructured":"Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, Yamada H, Yoshida T, Harigai M, Ichikawa Y (2008) Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Mod Rheumatol 18:34\u201344","journal-title":"Mod Rheumatol"},{"key":"8155_CR87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","volume":"56","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E (2001) A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 56:323\u2013327","journal-title":"Neurology"},{"key":"8155_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s004150050005","volume":"247","author":"MC Walter","year":"2000","unstructured":"Walter MC, Lochmuller H, Toepfer M, Schlotter B, Reilich P, Schroder M, Muller-Felber W, Pongratz D (2000) High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol 247:22\u201328","journal-title":"J Neurol"},{"key":"8155_CR89","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","volume":"48","author":"MC Dalakas","year":"1997","unstructured":"Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K (1997) Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology 48:712\u2013716","journal-title":"Neurology"},{"key":"8155_CR90","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/bjo.85.11.1287","volume":"85","author":"N Seider","year":"2001","unstructured":"Seider N, Beiran I, Scharf J, Miller B (2001) Intravenous immunoglobulin therapy for resistant ocular Behcet's disease. Br J Ophthalmol 85:1287\u20131288","journal-title":"Br J Ophthalmol"},{"key":"8155_CR91","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/014107689008301021","volume":"83","author":"E Rewald","year":"1990","unstructured":"Rewald E, Jaksic JC (1990) Behcet's syndrome treated with high-dose intravenous IgG and low-dose aspirin. J R Soc Med 83:652\u2013653","journal-title":"J R Soc Med"},{"key":"8155_CR92","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V86.2.797.bloodjournal862797","volume":"86","author":"RS Schwartz","year":"1995","unstructured":"Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM (1995) A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gamma globulin. Blood 86:797\u2013804","journal-title":"Blood"},{"key":"8155_CR93","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1046\/j.1365-2141.1996.d01-1965.x","volume":"95","author":"L Crenier","year":"1996","unstructured":"Crenier L, Ducobu J, des Grottes JM, Cerny J, Delaunoit C, Capel P (1996) Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor. Br J Haematol 95:750\u2013753","journal-title":"Br J Haematol"},{"key":"8155_CR94","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1532\/IJH97.06222","volume":"85","author":"K Yamamoto","year":"2007","unstructured":"Yamamoto K, Takamatsu J, Saito H (2007) Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review. Int J Hematol 85:287\u2013293","journal-title":"Int J Hematol"},{"key":"8155_CR95","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1365-2516.2001.00489.x","volume":"7","author":"AC Dykes","year":"2001","unstructured":"Dykes AC, Walker ID, Lowe GD, Tait RC (2001) Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia 7:160\u2013163","journal-title":"Haemophilia"},{"key":"8155_CR96","first-page":"121","volume":"81","author":"S Molica","year":"1996","unstructured":"Molica S, Musto P, Chiurazzi F, Specchia G, Brugiatelli M, Cicoira L, Levato D, Nobile F, Carotenuto M, Liso V, Rotoli B (1996) Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. Haematologica 81:121\u2013126","journal-title":"Haematologica"},{"key":"8155_CR97","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","volume":"73","author":"H Griffiths","year":"1989","unstructured":"Griffiths H, Brennan V, Lea J, Bunch C, Lee M, Chapel H (1989) Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors. Blood 73:366\u2013368","journal-title":"Blood"},{"key":"8155_CR98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2257.1995.tb00322.x","volume":"17","author":"BJ Boughton","year":"1995","unstructured":"Boughton BJ, Jackson N, Lim S, Smith N (1995) Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia. Clin Lab Haematol 17:75\u201380","journal-title":"Clin Lab Haematol"},{"key":"8155_CR99","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","volume":"343","author":"HM Chapel","year":"1994","unstructured":"Chapel HM, Lee M, Hargreaves R, Pamphilon DH, Prentice AG (1994) Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma. Lancet 343:1059\u20131063","journal-title":"Lancet"},{"key":"8155_CR100","first-page":"115","volume":"32","author":"A Gimesi","year":"1992","unstructured":"Gimesi A, Eibl M, Koos R, Somlo P, Magyarossy E, Kardos G, Fazekas E, Schmidt M, Borsi J, Schuler D (1992) Immunoglobulin prophylaxis during intensive treatment of acute lymphoblastic leukemia in children. Acta Paediatr Hung 32:115\u2013125","journal-title":"Acta Paediatr Hung"},{"key":"8155_CR101","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00595896","volume":"148","author":"T Sumer","year":"1989","unstructured":"Sumer T, Abumelha A, al-Mulhim I, al-Fadil M (1989) Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gamma globulin in childhood leukemia. Eur J Pediatr 148:401\u2013402","journal-title":"Eur J Pediatr"},{"key":"8155_CR102","first-page":"419","volume":"30","author":"C Bunch","year":"1988","unstructured":"Bunch C (1988) Immunoglobulin replacement in chronic lymphocytic leukaemia. Nouv Rev Fr Hematol 30:419\u2013422","journal-title":"Nouv Rev Fr Hematol"},{"key":"8155_CR103","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2141.1995.tb08447.x","volume":"89","author":"P Musto","year":"1995","unstructured":"Musto P, Brugiatelli M, Carotenuto M (1995) Prophylaxis against infections with intravenous immunoglobulins in multiple myeloma. Br J Haematol 89:945\u2013946","journal-title":"Br J Haematol"},{"key":"8155_CR104","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/08820139109050786","volume":"20","author":"H Chapel","year":"1991","unstructured":"Chapel H, Griffiths H, Brennan V, Bunch C, Lea J, Lee M (1991) Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy. Immunol Invest 20:187\u2013191","journal-title":"Immunol Invest"},{"key":"8155_CR105","first-page":"106","volume":"29","author":"OF Ballester","year":"1992","unstructured":"Ballester OF, Saba HI, Moscinski LC, Nelson R, Foulis P (1992) Pure red cell aplasia: treatment with intravenous immunoglobulin concentrate. Semin Hematol 29:106\u2013108","journal-title":"Semin Hematol"},{"key":"8155_CR106","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2141.1983.tb01260.x","volume":"55","author":"JP Clauvel","year":"1983","unstructured":"Clauvel JP, Vainchenker W, Herrera A, Dellagi K, Vinci G, Tabilio A, Lacombe C (1983) Treatment of pure red cell aplasia by high dose intravenous immunoglobulins. Br J Haematol 55:380\u2013382","journal-title":"Br J Haematol"},{"key":"8155_CR107","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/jmv.20870","volume":"79","author":"JW Tang","year":"2007","unstructured":"Tang JW, Lau JS, Wong SY, Cheung JL, Chan CH, Wong KF, Wong A, Chan PK (2007) Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection. J Med Virol 79:1401\u20131405","journal-title":"J Med Virol"},{"key":"8155_CR108","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3748\/wjg.v13.i13.2007","volume":"13","author":"TB Liang","year":"2007","unstructured":"Liang TB, Li DL, Yu J, Bai XL, Liang L, Xu SG, Wang WL, Shen Y, Zhang M, Zheng SS (2007) Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature. World J Gastroenterol 13:2007\u20132010","journal-title":"World J Gastroenterol"},{"key":"8155_CR109","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1399-3046.2005.00379.x","volume":"9","author":"MM Subtirelu","year":"2005","unstructured":"Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M (2005) Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Pediatr Transplant 9:801\u2013804","journal-title":"Pediatr Transplant"},{"key":"8155_CR110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2141.2002.03778.x","volume":"119","author":"KW Song","year":"2002","unstructured":"Song KW, Mollee P, Patterson B, Brien W, Crump M (2002) Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. Br J Haematol 119:125\u2013127","journal-title":"Br J Haematol"},{"key":"8155_CR111","first-page":"47","volume":"17","author":"R Castelli","year":"2002","unstructured":"Castelli R, Vismara A, Pavia G, Dagani R, Porro T (2002) Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate. Ann Ital Med Int 17:47\u201350","journal-title":"Ann Ital Med Int"},{"key":"8155_CR112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/003655402753395247","volume":"34","author":"SH Choi","year":"2002","unstructured":"Choi SH, Chang SP, Won JC, Lee JS, Chi HS, Yang WS, Park SK (2002) A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis 34:71\u201375","journal-title":"Scand J Infect Dis"},{"key":"8155_CR113","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5858\/2000-124-0441-FPIFET","volume":"124","author":"J Borkowski","year":"2000","unstructured":"Borkowski J, Amrikachi M, Hudnall SD (2000) Fulminant parvovirus infection following erythropoietin treatment in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 124:441\u2013445","journal-title":"Arch Pathol Lab Med"},{"key":"8155_CR114","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<16::AID-AJH4>3.0.CO;2-Y","volume":"61","author":"PR Koduri","year":"1999","unstructured":"Koduri PR, Kumapley R, Valladares J, Teter C (1999) Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin\u2014a report of eight patients. Am J Hematol 61:16\u201320","journal-title":"Am J Hematol"},{"key":"8155_CR115","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<222::AID-AJH9>3.0.CO;2-K","volume":"60","author":"T Chuhjo","year":"1999","unstructured":"Chuhjo T, Nakao S, Matsuda T (1999) Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol 60:222\u2013224","journal-title":"Am J Hematol"},{"key":"8155_CR116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s002770050315","volume":"75","author":"PR Koduri","year":"1997","unstructured":"Koduri PR, Kumapley R, Khokha ND, Patel AR (1997) Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin. Ann Hematol 75:67\u201368","journal-title":"Ann Hematol"},{"key":"8155_CR117","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/00313029600169154","volume":"28","author":"A Fuller","year":"1996","unstructured":"Fuller A, Moaven L, Spelman D, Spicer WJ, Wraight H, Curtis D, Leydon J, Doultree J, Locarnini S (1996) Parvovirus B19 in HIV infection: a treatable cause of anemia. Pathology 28:277\u2013280","journal-title":"Pathology"},{"key":"8155_CR118","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2141.1995.tb05250.x","volume":"91","author":"B Ramratnam","year":"1995","unstructured":"Ramratnam B, Gollerkeri A, Schiffman FJ, Rintels P, Flanigan TP (1995) Management of persistent B19 parvovirus infection in AIDS. Br J Haematol 91:90\u201392","journal-title":"Br J Haematol"},{"key":"8155_CR119","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2796.1994.tb00851.x","volume":"236","author":"MJ Mant","year":"1994","unstructured":"Mant MJ (1994) Chronic idiopathic pure red cell aplasia: successful treatment during pregnancy and durable response to intravenous immunoglobulin. J Intern Med 236:593\u2013595","journal-title":"J Intern Med"},{"key":"8155_CR120","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000204509","volume":"89","author":"Y Ilan","year":"1993","unstructured":"Ilan Y, Naparstek Y (1993) Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin. Acta Haematol 89:152\u2013154","journal-title":"Acta Haematol"},{"key":"8155_CR121","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(94)92659-X","volume":"343","author":"JK Ramage","year":"1994","unstructured":"Ramage JK, Hale A, Gane E, Cohen B, Boyle M, Mufti G, Williams R (1994) Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet 343:667\u2013668","journal-title":"Lancet"},{"key":"8155_CR122","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM198710153171606","volume":"317","author":"WA McGuire","year":"1987","unstructured":"McGuire WA, Yang HH, Bruno E, Brandt J, Briddell R, Coates TD, Hoffman R (1987) Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin. N Engl J Med 317:1004\u20131008","journal-title":"N Engl J Med"},{"key":"8155_CR123","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ajh.2830500319","volume":"50","author":"M Karmochkine","year":"1995","unstructured":"Karmochkine M, Oksenhendler E, Leruez-Ville M, Jaccard A, Morinet F, Herson S (1995) Persistent parvovirus B19 infection and pure red cell aplasia in Waldenstrom's macroglobulinemia: successful treatment with high-dose intravenous immunoglobulin. Am J Hematol 50:227\u2013228","journal-title":"Am J Hematol"},{"key":"8155_CR124","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","volume":"91","author":"H Mohri","year":"1998","unstructured":"Mohri H, Motomura S, Kanamori H, Matsuzaki M, Watanabe S, Maruta A, Kodama F, Okubo T (1998) Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 91:3623\u20133629","journal-title":"Blood"},{"key":"8155_CR125","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1365-2141.1999.01360.x","volume":"105","author":"JF Viallard","year":"1999","unstructured":"Viallard JF, Pellegrin JL, Vergnes C, Borel-Derlon A, Clofent-Sanchez G, Nurden AT, Leng B, Nurden P (1999) Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus. Br J Haematol 105:532\u2013537","journal-title":"Br J Haematol"},{"key":"8155_CR126","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00043426-199022000-00014","volume":"12","author":"PD Sadowitz","year":"1990","unstructured":"Sadowitz PD, Dubowy RL (1990) Intravenous immunoglobulin in the treatment of aplastic anemia. Am J Pediatr Hematol Oncol 12:198\u2013200","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"8155_CR127","first-page":"843","volume":"15","author":"GA Bergen","year":"1996","unstructured":"Bergen GA, Sakalosky PE, Sinnott JT (1996) Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient. J Heart Lung Transplant 15:843\u2013845","journal-title":"J Heart Lung Transplant"},{"key":"8155_CR128","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0953-6205(00)00067-4","volume":"11","author":"Y Sherer","year":"2000","unstructured":"Sherer Y, Levy Y, Fabbrizzi F, Shoenfeld Y (2000) Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIg)\u2014report of seven cases and review of the literature. Eur J Intern Med 11:85\u201388","journal-title":"Eur J Intern Med"},{"key":"8155_CR129","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ajh.2830440404","volume":"44","author":"G Flores","year":"1993","unstructured":"Flores G, Cunningham-Rundles C, Newland AC, Bussel JB (1993) Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol 44:237\u2013242","journal-title":"Am J Hematol"},{"key":"8155_CR130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","volume":"91","author":"J Bux","year":"1998","unstructured":"Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 91:181\u2013186","journal-title":"Blood"},{"key":"8155_CR131","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0002-9343(87)90547-X","volume":"83","author":"MW Hilgartner","year":"1987","unstructured":"Hilgartner MW, Bussel J (1987) Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. Am J Med 83:25\u201329","journal-title":"Am J Med"},{"key":"8155_CR132","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00043426-199709000-00005","volume":"19","author":"P Mathew","year":"1997","unstructured":"Mathew P, Chen G, Wang W (1997) Evans syndrome: results of a national survey. J Pediatr Hematol Oncol 19:433\u2013437","journal-title":"J Pediatr Hematol Oncol"},{"key":"8155_CR133","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00043426-199511000-00003","volume":"17","author":"A Scaradavou","year":"1995","unstructured":"Scaradavou A, Bussel J (1995) Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol. J Pediatr Hematol Oncol 17:290\u2013295","journal-title":"J Pediatr Hematol Oncol"},{"key":"8155_CR134","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/00043426-198722000-00012","volume":"9","author":"R Nuss","year":"1987","unstructured":"Nuss R, Wang W (1987) Intravenous gamma globulin for thrombocytopenia in children with Evans syndrome. Am J Pediatr Hematol Oncol 9:164\u2013167","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"8155_CR135","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s100670170107","volume":"20","author":"DK Chang","year":"2001","unstructured":"Chang DK, Yoo DH, Kim TH, Jun JB, Lee IH, Bae SC, Kim IS, Kim SY (2001) Induction of remission with intravenous immunoglobulin and cyclophosphamide in steroid-resistant Evans' syndrome associated with dermatomyositis. Clin Rheumatol 20:63\u201366","journal-title":"Clin Rheumatol"},{"key":"8155_CR136","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","volume":"100","author":"C Kaplan","year":"1998","unstructured":"Kaplan C, Murphy MF, Kroll H, Waters AH (1998) Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids\u2014more questions than answers. European Working Group on FMAIT. Br J Haematol 100:62\u201365","journal-title":"Br J Haematol"},{"key":"8155_CR137","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","volume":"139","author":"C Cordonnier","year":"2003","unstructured":"Cordonnier C, Chevret S, Legrand M, Rafi H, Dhedin N, Lehmann B, Bassompierre F, Gluckman E (2003) Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 139:8\u201318","journal-title":"Ann Intern Med"},{"key":"8155_CR138","first-page":"132","volume":"83","author":"P Zikos","year":"1998","unstructured":"Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A (1998) A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT). Haematologica 83:132\u2013137","journal-title":"Haematologica"},{"key":"8155_CR139","first-page":"44","volume":"2","author":"KM Sullivan","year":"1996","unstructured":"Sullivan KM, Storek J, Kopecky KJ, Jocom J, Longton G, Flowers M, Siadak M, Nims J, Witherspoon RP, Anasetti C, Appelbaum FR, Bowden RA, Buckner CD, Crawford SW, Deeg HJ, Hansen JA, McDonald GB, Sanders JE, Storb R (1996) A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 2:44\u201353","journal-title":"Biol Blood Marrow Transplant"},{"key":"8155_CR140","first-page":"283","volume":"12","author":"DJ Winston","year":"1993","unstructured":"Winston DJ, Ho WG, Bartoni K, Champlin RE (1993) Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients. Bone Marrow Transplant 12:283\u2013288","journal-title":"Bone Marrow Transplant"},{"key":"8155_CR141","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/sj.bmt.1703109","volume":"28","author":"DJ Winston","year":"2001","unstructured":"Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA (2001) A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 28:187\u2013196","journal-title":"Bone Marrow Transplant"},{"key":"8155_CR142","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-118-12-199306150-00004","volume":"118","author":"SN Wolff","year":"1993","unstructured":"Wolff SN, Fay JW, Herzig RH, Greer JP, Dummer S, Brown RA, Collins RH, Stevens DA, Herzig GP (1993) High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group. Ann Intern Med 118:937\u2013942","journal-title":"Ann Intern Med"},{"key":"8155_CR143","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","volume":"323","author":"KM Sullivan","year":"1990","unstructured":"Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Peterson FB, Witherspoon RP et al (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705\u2013712","journal-title":"N Engl J Med"},{"key":"8155_CR144","first-page":"CD003313","volume":"3","author":"GS Alcock","year":"2002","unstructured":"Alcock GS, Liley H (2002) Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 3:CD003313","journal-title":"Cochrane Database Syst Rev"},{"key":"8155_CR145","doi-asserted-by":"publisher","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","volume":"88","author":"R Gottstein","year":"2003","unstructured":"Gottstein R, Cooke RW (2003) Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 88:F6\u2013F10","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"8155_CR146","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1423-0410.1994.tb01659.x","volume":"67","author":"AI Kohan","year":"1994","unstructured":"Kohan AI, Niborski RC, Rey JA, Amerise G, Vazquez MI, Zani N, Calahonra R, Binaghi A, Sanchez Avalos J (1994) High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility. Vox Sang 67:195\u2013198","journal-title":"Vox Sang"},{"key":"8155_CR147","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2257.1993.tb00122.x","volume":"15","author":"BE Woodcock","year":"1993","unstructured":"Woodcock BE, Walker S, Adams K (1993) Haemolytic transfusion reaction\u2014successful attenuation with methylprednisolone and high dose immunoglobulin. Clin Lab Haematol 15:59\u201361","journal-title":"Clin Lab Haematol"},{"key":"8155_CR148","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1537-2995.2001.41030323.x","volume":"41","author":"N Win","year":"2001","unstructured":"Win N, Doughty H, Telfer P, Wild BJ, Pearson TC (2001) Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 41:323\u2013328","journal-title":"Transfusion"},{"key":"8155_CR149","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/10245330400001926","volume":"9","author":"N Win","year":"2004","unstructured":"Win N, Yeghen T, Needs M, Chen FE, Okpala I (2004) Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 9:433\u2013436","journal-title":"Hematology"},{"key":"8155_CR150","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1423-0410.1995.tb00373.x","volume":"69","author":"JO Cullis","year":"1995","unstructured":"Cullis JO, Win N, Dudley JM, Kaye T (1995) Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 69:355\u2013357","journal-title":"Vox Sang"},{"key":"8155_CR151","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00867478","volume":"5","author":"WL Robson","year":"1991","unstructured":"Robson WL, Fick GH, Jadavji T, Leung AK (1991) The use of intravenous gamma globulin in the treatment of typical hemolytic uremic syndrome. Pediatr Nephrol 5:289\u2013292","journal-title":"Pediatr Nephrol"},{"key":"8155_CR152","first-page":"268","volume":"144","author":"KJ Sheth","year":"1990","unstructured":"Sheth KJ, Gill JC, Leichter HE (1990) High-dose intravenous gamma globulin infusions in hemolytic\u2013uremic syndrome: a preliminary report. Am J Dis Child 144:268\u2013270","journal-title":"Am J Dis Child"},{"key":"8155_CR153","first-page":"325","volume":"80","author":"R Centurioni","year":"1995","unstructured":"Centurioni R, Bobbio-Pallavicini E, Porta C, Rodeghiero F, Gugliotta L, Billio A, Tacconi F, Ascari E (1995) Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP. Haematologica 80:325\u2013331","journal-title":"Haematologica"},{"key":"8155_CR154","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000046567","volume":"105","author":"J Dervenoulas","year":"2001","unstructured":"Dervenoulas J, Tsirigotis P, Bollas G, Koumarianou AA, Pappa V, Mantzios G, Xiros N, Economopoulos T, Papageorgiou E, Pappa M, Raptis SA (2001) Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases. Acta Haematol 105:204\u2013208","journal-title":"Acta Haematol"},{"key":"8155_CR155","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1023\/A:1023238915316","volume":"18","author":"A Winder","year":"1998","unstructured":"Winder A, Shoenfeld Y, Hochman R, Keren G, Levy Y, Eldor A (1998) High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response. J Clin Immunol 18:330\u2013334","journal-title":"J Clin Immunol"},{"key":"8155_CR156","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1055\/s-2008-1062518","volume":"117","author":"A Prull","year":"1992","unstructured":"Prull A, Nechwatal R, Riedel H, Maurer W (1992) The therapy of the heparin-induced thrombosis\u2013thrombocytopenia syndrome with immunoglobulins. Dtsch Med Wochenschr 117:1838\u20131842","journal-title":"Dtsch Med Wochenschr"},{"key":"8155_CR157","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1537-2995.1994.34994378275.x","volume":"34","author":"L Jahnke","year":"1994","unstructured":"Jahnke L, Applebaum S, Sherman LA, Greenberger PA, Green D (1994) An evaluation of intravenous immunoglobulin in the treatment of human immunodeficiency virus-associated thrombocytopenia. Transfusion 34:759\u2013764","journal-title":"Transfusion"},{"key":"8155_CR158","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","volume":"359","author":"B Godeau","year":"2002","unstructured":"Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F, Cheze S, Legouffe E, Hulin C, Grange MJ, Fain O, Bierling P (2002) Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 359:23\u201329","journal-title":"Lancet"},{"key":"8155_CR159","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/BF00320256","volume":"59","author":"P Jacobs","year":"1989","unstructured":"Jacobs P, Wood L (1989) The comparison of gamma globulin to steroids in treating adult immune thrombocytopenia. An interim analysis. Blut 59:92\u201395","journal-title":"Blut"},{"key":"8155_CR160","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0022-3476(05)80400-7","volume":"123","author":"VS Blanchette","year":"1993","unstructured":"Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M (1993) A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 123:989\u2013995","journal-title":"J Pediatr"},{"key":"8155_CR161","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/08880010252899370","volume":"19","author":"F Duru","year":"2002","unstructured":"Duru F, Fisgin T, Yarali N, Kara A (2002) Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Pediatr Hematol Oncol 19:219\u2013225","journal-title":"Pediatr Hematol Oncol"},{"key":"8155_CR162","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajh.2830380402","volume":"38","author":"MU Rarick","year":"1991","unstructured":"Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM (1991) Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia. Am J Hematol 38:261\u2013266","journal-title":"Am J Hematol"},{"key":"8155_CR163","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<127::AID-AJH5>3.0.CO;2-#","volume":"59","author":"A Majluf-Cruz","year":"1998","unstructured":"Majluf-Cruz A, Luna-Castanos G, Huitron S, Nieto-Cisneros L (1998) Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS. Am J Hematol 59:127\u2013132","journal-title":"Am J Hematol"},{"key":"8155_CR164","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.thj.6200303","volume":"4","author":"M Colovic","year":"2003","unstructured":"Colovic M, Dimitrijevic M, Sonnenburg C, Suvajdzic N, Donfrid M, Bogdanovic A (2003) Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP. Hematol J 4:358\u2013362","journal-title":"Hematol J"},{"key":"8155_CR165","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V82.5.1415.bloodjournal8251415","volume":"82","author":"B Godeau","year":"1993","unstructured":"Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P (1993) Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood 82:1415\u20131421","journal-title":"Blood"},{"key":"8155_CR166","first-page":"287","volume":"308","author":"C Mueller-Eckhardt","year":"1983","unstructured":"Mueller-Eckhardt C, Kuenzlen E, Thilo-Korner D, Pralle H (1983) High-dose intravenous immunoglobulin for post-transfusion purpura. N Engl J Med 308:287","journal-title":"N Engl J Med"},{"key":"8155_CR167","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2141.1985.tb04071.x","volume":"61","author":"T Becker","year":"1985","unstructured":"Becker T, Panzer S, Maas D, Kiefel V, Sprenger R, Kirschbaum M, Mueller-Eckhardt C (1985) High-dose intravenous immunoglobulin for post-transfusion purpura. Br J Haematol 61:149\u2013155","journal-title":"Br J Haematol"},{"key":"8155_CR168","first-page":"323","volume":"57","author":"WS Walker","year":"1988","unstructured":"Walker WS, Yap PL, Kilpatrick DC, Boulton FE, Crawford RJ, Sang CT (1988) Post-transfusion purpura following open heart surgery: management by high dose intravenous immunoglobulin infusion. Ann Hematol 57:323\u2013325","journal-title":"Ann Hematol"},{"key":"8155_CR169","first-page":"322","volume":"19","author":"G Asci","year":"2006","unstructured":"Asci G, Toz H, Ozkahya M, Cagirgan S, Duman S, Sezis S, Ok E (2006) High-dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome. J Nephrol 19:322\u2013326","journal-title":"J Nephrol"},{"key":"8155_CR170","first-page":"157","volume":"37","author":"CJ Chen","year":"2004","unstructured":"Chen CJ, Huang YC, Jaing TH, Hung IJ, Yang CP, Chang LY, Lin TY (2004) Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect 37:157\u2013163","journal-title":"J Microbiol Immunol Infect"},{"key":"8155_CR171","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2141.1995.tb03302.x","volume":"89","author":"RL Chen","year":"1995","unstructured":"Chen RL, Lin KH, Lin DT, Su IJ, Huang LM, Lee PI, Hseih KH, Lin KS, Lee CY (1995) Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 89:282\u2013290","journal-title":"Br J Haematol"},{"key":"8155_CR172","first-page":"1141","volume":"83","author":"V Ningsanond","year":"2000","unstructured":"Ningsanond V (2000) Infection associated hemophagocytic syndrome: a report of 50 children. J Med Assoc Thai 83:1141\u20131149","journal-title":"J Med Assoc Thai"},{"key":"8155_CR173","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0022-3476(05)81761-5","volume":"123","author":"B Freeman","year":"1993","unstructured":"Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P (1993) Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 123:479\u2013481","journal-title":"J Pediatr"},{"key":"8155_CR174","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ajh.21008","volume":"83","author":"A Hot","year":"2008","unstructured":"Hot A, Madoux MH, Viard JP, Coppere B, Ninet J (2008) Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins. Am J Hematol 83:159\u2013162","journal-title":"Am J Hematol"},{"key":"8155_CR175","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0022-510X(98)00107-5","volume":"158","author":"J Benito-Leon","year":"1998","unstructured":"Benito-Leon J, Lopez-Rios F, Rodriguez-Martin FJ, Madero S, Ruiz J (1998) Rapidly deteriorating polyneuropathy associated with osteosclerotic myeloma responsive to intravenous immunoglobulin and radiotherapy. J Neurol Sci 158:113\u2013117","journal-title":"J Neurol Sci"},{"key":"8155_CR176","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/BF00873980","volume":"243","author":"CC Huang","year":"1996","unstructured":"Huang CC, Chu CC (1996) Poor response to intravenous immunoglobulin therapy in patients with Castleman's disease and the POEMS syndrome. J Neurol 243:726\u2013727","journal-title":"J Neurol"},{"key":"8155_CR177","first-page":"366","volume":"58","author":"YJ Chang","year":"1996","unstructured":"Chang YJ, Huang CC, Chu CC (1996) Intravenous immunoglobulin therapy in POEMS syndrome: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 58:366\u2013369","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"8155_CR178","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-0012.1998.tb01078.x","volume":"12","author":"M Cantarovich","year":"1998","unstructured":"Cantarovich M, Barkun JS, Forbes RD, Kosiuk JP, Tchervenkov JI (1998) Successful treatment of post-transplant lymphoproliferative disorder with interferon-alpha and intravenous immunoglobulin. Clin Transplant 12:109\u2013115","journal-title":"Clin Transplant"},{"key":"8155_CR179","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.transproceed.2006.07.001","volume":"38","author":"F Leroy","year":"2006","unstructured":"Leroy F, Sechet A, Abou Ayache R, Thierry A, Belmouaz S, Desport E, Bauwens M, Bridoux F, Touchard G (2006) Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients. Transplant Proc 38:2324\u20132326","journal-title":"Transplant Proc"},{"key":"8155_CR180","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM199107113250201","volume":"325","author":"The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group","year":"1991","unstructured":"The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group (1991) Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 325:73\u201380","journal-title":"N Engl J Med"},{"key":"8155_CR181","first-page":"543","volume":"89","author":"L Olopoenia","year":"1997","unstructured":"Olopoenia L, Young M, White D, Barnes S, Rahbar F, Fomufod A (1997) Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection. J Natl Med Assoc 89:543\u2013547","journal-title":"J Natl Med Assoc"},{"key":"8155_CR182","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2141.1992.tb08249.x","volume":"81","author":"JD Goldring","year":"1992","unstructured":"Goldring JD, Molyneux ME, Taylor T, Wirima J, Hommel M (1992) Plasmodium falciparum: diversity of isolates from Malawi in their cytoadherence to melanoma cells and monocytes in vitro. Br J Haematol 81:413\u2013418","journal-title":"Br J Haematol"},{"key":"8155_CR183","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","volume":"45","author":"A Sabchareon","year":"1991","unstructured":"Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P (1991) Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 45:297\u2013308","journal-title":"Am J Trop Med Hyg"},{"key":"8155_CR184","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1474-4422(06)70447-1","volume":"5","author":"H Gonzalez","year":"2006","unstructured":"Gonzalez H, Sunnerhagen KS, Sjoberg I, Kaponides G, Olsson T, Borg K (2006) Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol 5:493\u2013500","journal-title":"Lancet Neurol"},{"key":"8155_CR185","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1468-1331.2006.01552.x","volume":"14","author":"E Farbu","year":"2007","unstructured":"Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA (2007) Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol 14:60\u201365","journal-title":"Eur J Neurol"},{"key":"8155_CR186","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/16501970500441625","volume":"38","author":"G Kaponides","year":"2006","unstructured":"Kaponides G, Gonzalez H, Olsson T, Borg K (2006) Effect of intravenous immunoglobulin in patients with post-polio syndrome\u2014an uncontrolled pilot study. J Rehabil Med 38:138\u2013140","journal-title":"J Rehabil Med"},{"key":"8155_CR187","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1097\/01.CCM.0000295312.13466.1C","volume":"35","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35:2686\u20132692","journal-title":"Crit Care Med"},{"key":"8155_CR188","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1399-3062.2002.01014.x","volume":"4","author":"A Hamdan","year":"2002","unstructured":"Hamdan A, Green P, Mendelson E, Kramer MR, Pitlik S, Weinberger M (2002) Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 4:160\u2013162","journal-title":"Transpl Infect Dis"},{"key":"8155_CR189","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3201\/eid0704.010432","volume":"7","author":"Z Shimoni","year":"2001","unstructured":"Shimoni Z, Niven MJ, Pitlick S, Bulvik S (2001) Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 7:759","journal-title":"Emerg Infect Dis"},{"key":"8155_CR190","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJM199207233270404","volume":"327","author":"The Intravenous Immunoglobulin Collaborative Study Group","year":"1992","unstructured":"The Intravenous Immunoglobulin Collaborative Study Group (1992) Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N Engl J Med 327:234\u2013240","journal-title":"N Engl J Med"},{"key":"8155_CR191","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF00273538","volume":"11","author":"W Glinz","year":"1985","unstructured":"Glinz W, Grob PJ, Nydegger UE, Ricklin T, Stamm F, Stoffel D, Lasance A (1985) Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study. Intensive Care Med 11:288\u2013294","journal-title":"Intensive Care Med"},{"key":"8155_CR192","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00004630-198709000-00007","volume":"8","author":"AM Munster","year":"1987","unstructured":"Munster AM, Moran KT, Thupari J, Allo M, Winchurch RA (1987) Prophylactic intravenous immunoglobulin replacement in high-risk burn patients. J Burn Care Rehabil 8:376\u2013380","journal-title":"J Burn Care Rehabil"},{"key":"8155_CR193","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0883-9441(93)90004-5","volume":"8","author":"AM Gooding","year":"1993","unstructured":"Gooding AM, Bastian JF, Peterson BM, Wilson NW (1993) Safety and efficacy of intravenous immunoglobulin prophylaxis in pediatric head trauma patients: a double-blind controlled trial. J Crit Care 8:212\u2013216","journal-title":"J Crit Care"},{"key":"8155_CR194","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00003246-200001000-00002","volume":"28","author":"EE Douzinas","year":"2000","unstructured":"Douzinas EE, Pitaridis MT, Louris G, Andrianakis I, Katsouyanni K, Karmpaliotis D, Economidou J, Syfras D, Roussos C (2000) Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins. Crit Care Med 28:8\u201315","journal-title":"Crit Care Med"},{"key":"8155_CR195","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/00003246-199907000-00011","volume":"27","author":"HG Kress","year":"1999","unstructured":"Kress HG, Scheidewig C, Schmidt H, Silber R (1999) Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27:1281\u20131287","journal-title":"Crit Care Med"},{"key":"8155_CR196","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2141.1994.tb05002.x","volume":"88","author":"H Chapel","year":"1994","unstructured":"Chapel H, Dicato M, Gamm H, Brennan V, Ries F, Bunch C, Lee M (1994) Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes. Br J Haematol 88:209\u2013212","journal-title":"Br J Haematol"},{"key":"8155_CR197","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/00006534-199905060-00003","volume":"103","author":"CT Haywood","year":"1999","unstructured":"Haywood CT, McGeer A, Low DE (1999) Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 103:1567\u20131573","journal-title":"Plast Reconstr Surg"},{"key":"8155_CR198","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/00365540410020866","volume":"37","author":"A Norrby-Teglund","year":"2005","unstructured":"Norrby-Teglund A, Muller MP, McGeer A, Gan BS, Guru V, Bohnen J, Thulin P, Low DE (2005) Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 37:166\u2013172","journal-title":"Scand J Infect Dis"},{"key":"8155_CR199","first-page":"2642","volume":"101","author":"B Arnholm","year":"2004","unstructured":"Arnholm B, Lundqvist A, Stromberg A (2004) High-dose immunoglobulin\u2014life-saving in invasive group A streptococcal infection. Report of eleven cases with only one fatality. Lakartidningen 101:2642\u20132644","journal-title":"Lakartidningen"},{"key":"8155_CR200","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/ndt\/17.1.150","volume":"17","author":"A Korzets","year":"2002","unstructured":"Korzets A, Ori Y, Zevin D, Weinberger M, Kesslin J, Seror D, Kuperman A, Gafter U (2002) Group A streptococcal bacteraemia and necrotizing fasciitis in a renal transplant patient: a case for intravenous immunoglobulin therapy. Nephrol Dial Transplant 17:150\u2013152","journal-title":"Nephrol Dial Transplant"},{"key":"8155_CR201","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0165-5876(86)80035-0","volume":"11","author":"O Kalm","year":"1986","unstructured":"Kalm O, Prellner K, Christensen P (1986) The effect of intravenous immunoglobulin treatment in recurrent acute otitis media. Int J Pediatr Otorhinolaryngol 11:237\u2013246","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"8155_CR202","first-page":"21","volume":"64","author":"HJ Silk","year":"1990","unstructured":"Silk HJ, Ambrosino D, Geha RS (1990) Effect of intravenous gamma globulin therapy in IgG2 deficient and IgG2 sufficient children with recurrent infections and poor response to immunization with Haemophilus influenzae type b capsular polysaccharide antigen. Ann Allergy 64:21\u201325","journal-title":"Ann Allergy"},{"key":"8155_CR203","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s004310000640","volume":"160","author":"YC Huang","year":"2001","unstructured":"Huang YC, Lin TY, Lin YJ, Lien RI, Chou YH (2001) Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr 160:91\u201394","journal-title":"Eur J Pediatr"},{"key":"8155_CR204","first-page":"53","volume":"36","author":"SJ Lin","year":"1995","unstructured":"Lin SJ, Lin TY, Chiu CH, Huang YC (1995) Experience of intravenous immunoglobulin and acyclovir in neonates at risk for severe varicella infection\u2014report of five cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 36:53\u201357","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"8155_CR205","first-page":"251","volume":"36","author":"M Saitou","year":"1998","unstructured":"Saitou M, Niitsuma K, Kasukawa R (1998) Two cases of severe adult varicella pneumonia. Nihon Kokyuki Gakkai Zasshi 36:251\u2013255","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"8155_CR206","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2169\/internalmedicine.35.315","volume":"35","author":"T Shirai","year":"1996","unstructured":"Shirai T, Sano K, Matsuyama S, Honjo Y, Takashima M, Sasada Y, Takayanagi S, Nagamatsu K, Nawano M, Fushimi M, Imokawa S, Sato A (1996) Varicella pneumonia in a healthy adult presenting with severe respiratory failure. Intern Med 35:315\u2013318","journal-title":"Intern Med"},{"key":"8155_CR207","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/147323000102900313","volume":"29","author":"O Tokat","year":"2001","unstructured":"Tokat O, Kelebek N, Turker G, Kahveci SF, Ozcan B (2001) Intravenous immunoglobulin in adult varicella pneumonia complicated by acute respiratory distress syndrome. J Int Med Res 29:252\u2013255","journal-title":"J Int Med Res"},{"key":"8155_CR208","first-page":"778","volume":"98","author":"DW Chou","year":"1999","unstructured":"Chou DW, Lee CH, Chen CW, Chang HY, Hsiue TR (1999) Varicella pneumonia complicated by acute respiratory distress syndrome in an adult. J Formos Med Assoc 98:778\u2013782","journal-title":"J Formos Med Assoc"},{"key":"8155_CR209","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/BF00441611","volume":"146","author":"T Hara","year":"1987","unstructured":"Hara T, Mizuno Y, Igarashi H, Ueda K (1987) Intravenous gamma globulin therapy for thrombocytopenic purpura associated with active varicella infection. Eur J Pediatr 146:531\u2013532","journal-title":"Eur J Pediatr"},{"key":"8155_CR210","first-page":"1142","volume":"42","author":"K Kaneda","year":"2001","unstructured":"Kaneda K, Kojima K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M (2001) An adult patient with varicella preceded by acute thrombocytopenia. Rinsho Ketsueki 42:1142\u20131144","journal-title":"Rinsho Ketsueki"},{"key":"8155_CR211","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/S0140-6736(04)17356-X","volume":"364","author":"PF Whitington","year":"2004","unstructured":"Whitington PF, Hibbard JU (2004) High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364:1690\u20131698","journal-title":"Lancet"},{"key":"8155_CR212","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1471-0528.2006.01201.x","volume":"114","author":"B Hutton","year":"2007","unstructured":"Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M (2007) Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 114:134\u2013142","journal-title":"BJOG"},{"key":"8155_CR213","first-page":"CD000112","volume":"4","author":"TF Porter","year":"2006","unstructured":"Porter TF, LaCoursiere Y, Scott JR (2006) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 4:CD000112","journal-title":"Cochrane Database Syst Rev"},{"key":"8155_CR214","first-page":"S226","volume":"86","author":"The Practice Committee of the American Society for Reproductive Medicine","year":"2006","unstructured":"The Practice Committee of the American Society for Reproductive Medicine (2006) Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss. Fertil Steril 86:S226\u2013S227","journal-title":"Fertil Steril"},{"key":"8155_CR215","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/humrep\/17.3.809","volume":"17","author":"OB Christiansen","year":"2002","unstructured":"Christiansen OB, Pedersen B, Rosgaard A, Husth M (2002) A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 17:809\u2013816","journal-title":"Hum Reprod"},{"key":"8155_CR216","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/humupd\/5.5.475","volume":"5","author":"S Daya","year":"1999","unstructured":"Daya S, Gunby J, Porter F, Scott J, Clark DA (1999) Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Hum Reprod Update 5:475\u2013482","journal-title":"Hum Reprod Update"},{"key":"8155_CR217","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/humrep\/12.11.2388","volume":"12","author":"A Perino","year":"1997","unstructured":"Perino A, Vassiliadis A, Vucetich A, Colacurci N, Menato G, Cignitti M, Semprini AE (1997) Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study. Hum Reprod 12:2388\u20132392","journal-title":"Hum Reprod"},{"key":"8155_CR218","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0897.1995.tb00960.x","volume":"34","author":"CB Coulam","year":"1995","unstructured":"Coulam CB, Krysa L, Stern JJ, Bustillo M (1995) Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 34:333\u2013337","journal-title":"Am J Reprod Immunol"},{"key":"8155_CR219","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/oxfordjournals.humrep.a135769","volume":"10","author":"OB Christiansen","year":"1995","unstructured":"Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N (1995) Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 10:2690\u20132695","journal-title":"Hum Reprod"},{"key":"8155_CR220","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-0528.1994.tb13584.x","volume":"101","author":"The German RSA\/IVIG Group","year":"1994","unstructured":"The German RSA\/IVIG Group (1994) Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 101:1072\u20131077","journal-title":"Br J Obstet Gynaecol"},{"key":"8155_CR221","first-page":"CD002859","volume":"2","author":"M Empson","year":"2005","unstructured":"Empson M, Lassere M, Craig J, Scott J (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2:CD002859","journal-title":"Cochrane Database Syst Rev"},{"key":"8155_CR222","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/art.10957","volume":"48","author":"G Triolo","year":"2003","unstructured":"Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarratano A, Licata G (2003) Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48:728\u2013731","journal-title":"Arthritis Rheum"},{"key":"8155_CR223","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"DW Branch","year":"2000","unstructured":"Branch DW, Peaceman AM, Druzin M, Silver RK, El-Sayed Y, Silver RM, Esplin MS, Spinnato J, Harger J (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182:122\u2013127","journal-title":"Am J Obstet Gynecol"},{"key":"8155_CR224","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.8755-8920.2001.450309.x","volume":"45","author":"E Vaquero","year":"2001","unstructured":"Vaquero E, Lazzarin N, Valensise H, Menghini S, Di Pierro G, Cesa F, Romanini C (2001) Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. Am J Reprod Immunol 45:174\u2013179","journal-title":"Am J Reprod Immunol"},{"key":"8155_CR225","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0029-7844(98)00437-2","volume":"93","author":"AL Clark","year":"1999","unstructured":"Clark AL, Branch DW, Silver RM, Harris EN, Pierangeli S, Spinnato JA (1999) Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy. Obstet Gynecol 93:437\u2013441","journal-title":"Obstet Gynecol"},{"key":"8155_CR226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0897.1998.tb00394.x","volume":"40","author":"G Sher","year":"1998","unstructured":"Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W (1998) The selective use of heparin\/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 40:74\u201382","journal-title":"Am J Reprod Immunol"},{"key":"8155_CR227","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3109\/00016349609055029","volume":"75","author":"K Marzusch","year":"1996","unstructured":"Marzusch K, Dietl J, Klein R, Hornung D, Neuer A, Berg PA (1996) Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: a pilot study of treatment with intravenous immunoglobulin. Acta Obstet Gynecol Scand 75:922\u2013926","journal-title":"Acta Obstet Gynecol Scand"},{"key":"8155_CR228","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/pd.1970150603","volume":"15","author":"H Valensise","year":"1995","unstructured":"Valensise H, Vaquero E, De Carolis C, Stipa E, Perricone R, Arduini D, Romanini C (1995) Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG). Prenat Diagn 15:509\u2013517","journal-title":"Prenat Diagn"},{"key":"8155_CR229","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/jpme.1992.20.2.101","volume":"20","author":"M Hockel","year":"1992","unstructured":"Hockel M, Queisser-Luft A, Beck T, Zielberg R, Stopfkuchen H, Lissner R (1992) The effect of antenatal intravenous immunoglobulin on ascending intrauterine infection after preterm premature rupture of the membranes: a pilot study. J Perinat Med 20:101\u2013110","journal-title":"J Perinat Med"},{"key":"8155_CR230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10815-005-9013-1","volume":"23","author":"DA Clark","year":"2006","unstructured":"Clark DA, Coulam CB, Stricker RB (2006) Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 23:1\u201313","journal-title":"J Assist Reprod Genet"},{"key":"8155_CR231","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0015-0282(00)01622-8","volume":"74","author":"MD Stephenson","year":"2000","unstructured":"Stephenson MD, Fluker MR (2000) Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial. Fertil Steril 74:1108\u20131113","journal-title":"Fertil Steril"},{"key":"8155_CR232","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0735-1097(99)00161-8","volume":"34","author":"B Bozkurt","year":"1999","unstructured":"Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, Murali S, Rosenblum WD, Feldman AM, McNamara DM (1999) Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 34:177\u2013180","journal-title":"J Am Coll Cardiol"},{"key":"8155_CR233","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0167-5273(03)00002-0","volume":"91","author":"C Kishimoto","year":"2003","unstructured":"Kishimoto C, Shioji K, Kinoshita M, Iwase T, Tamaki S, Fujii M, Murashige A, Maruhashi H, Takeda S, Nonogi H, Hashimoto T (2003) Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 91:173\u2013178","journal-title":"Int J Cardiol"},{"key":"8155_CR234","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.89.1.252","volume":"89","author":"NA Drucker","year":"1994","unstructured":"Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89:252\u2013257","journal-title":"Circulation"},{"key":"8155_CR235","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1542\/peds.96.6.1057","volume":"96","author":"K Durongpisitkul","year":"1995","unstructured":"Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057\u20131061","journal-title":"Pediatrics"},{"key":"8155_CR236","first-page":"CD004000","volume":"4","author":"RM Oates-Whitehead","year":"2003","unstructured":"Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 4:CD004000","journal-title":"Cochrane Database Syst Rev"},{"key":"8155_CR237","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341\u2013347","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"8155_CR238","first-page":"S1121","volume":"85","author":"P Khowsathit","year":"2002","unstructured":"Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S (2002) Treatment of Kawasaki disease with a moderate dose (1\u00a0g\/kg) of intravenous immunoglobulin. J Med Assoc Thai 85(Suppl 4):S1121\u2013S1126","journal-title":"J Med Assoc Thai"},{"key":"8155_CR239","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpeds.2005.08.024","volume":"148","author":"MH Tsai","year":"2006","unstructured":"Tsai MH, Huang YC, Yen MH, Li CC, Chiu CH, Lin PY, Lin TY, Chang LY (2006) Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin. J Pediatr 148:38\u201343","journal-title":"J Pediatr"},{"key":"8155_CR240","first-page":"891","volume":"44","author":"LJ Qin","year":"2006","unstructured":"Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX (2006) Therapeutic effectiveness of intravenous immunoglobulin at 1\u00a0g\/kg and 2\u00a0g\/kg on Kawasaki disease: a comparative and follow-up study. Zhonghua Er Ke Za Zhi 44:891\u2013895","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"8155_CR241","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00431-006-0280-3","volume":"166","author":"K Sakata","year":"2007","unstructured":"Sakata K, Hamaoka K, Ozawa S, Niboshi A, Yoshihara T, Nishiki T, Nakagawa Y, Kazuta K, Morimoto Y, Kamiya Y, Yamamoto T, Horii Y, Kido S (2007) A randomized prospective study on the use of 2\u00a0g-IVIG or 1\u00a0g-IVIG as therapy for Kawasaki disease. Eur J Pediatr 166:565\u2013571","journal-title":"Eur J Pediatr"},{"key":"8155_CR242","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633\u20131639","journal-title":"N Engl J Med"},{"key":"8155_CR243","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.CIR.103.3.401","volume":"103","author":"LM Voss","year":"2001","unstructured":"Voss LM, Wilson NJ, Neutze JM, Whitlock RM, Ameratunga RV, Cairns LM, Lennon DR (2001) Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation 103:401\u2013406","journal-title":"Circulation"},{"key":"8155_CR244","doi-asserted-by":"crossref","first-page":"II229","DOI":"10.1161\/circ.100.suppl_2.Ii-229","volume":"100","author":"R John","year":"1999","unstructured":"John R, Lietz K, Burke E, Ankersmit J, Mancini D, Suciu-Foca N, Edwards N, Rose E, Oz M, Itescu S (1999) Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 100:II229\u2013II235","journal-title":"Circulation"},{"key":"8155_CR245","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.athoracsur.2006.04.017","volume":"82","author":"SG Drakos","year":"2006","unstructured":"Drakos SG, Kfoury AG, Long JW, Stringham JC, Fuller TC, Nelson KE, Campbell BK, Gilbert EM, Renlund DG (2006) Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg 82:889\u2013893","journal-title":"Ann Thorac Surg"},{"key":"8155_CR246","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jtcvs.2006.12.019","volume":"133","author":"SR Meyer","year":"2007","unstructured":"Meyer SR, Ross DB, Forbes K, Hawkins LE, Halpin AM, Nahirniak SN, Rutledge JM, Rebeyka IM, Campbell PM (2007) Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery. J Thorac Cardiovasc Surg 133:1517\u20131523","journal-title":"J Thorac Cardiovasc Surg"},{"key":"8155_CR247","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0161-6420(00)00245-1","volume":"107","author":"E Letko","year":"2000","unstructured":"Letko E, Bhol K, Foster CS, Ahmed AR (2000) Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy. Ophthalmology 107:1524\u20131528","journal-title":"Ophthalmology"},{"key":"8155_CR248","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","volume":"56","author":"JH Noseworthy","year":"2001","unstructured":"Noseworthy JH, O'Brien PC, Petterson TM, Weis J, Stevens L, Peterson WK, Sneve D, Cross SA, Leavitt JA, Auger RG, Weinshenker BG, Dodick DW, Wingerchuk DM, Rodriguez M (2001) A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology 56:1514\u20131522","journal-title":"Neurology"},{"key":"8155_CR249","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","volume":"64","author":"HG Roed","year":"2005","unstructured":"Roed HG, Langkilde A, Sellebjerg F, Lauritzen M, Bang P, Morup A, Frederiksen JL (2005) A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology 64:804\u2013810","journal-title":"Neurology"},{"key":"8155_CR250","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1089\/thy.2005.15.398","volume":"15","author":"Z Symon","year":"2005","unstructured":"Symon Z, Schneebaum N, Eyal A, Tal S, Rozen N, Shoenfeld Y (2005) Successful intravenous immunoglobulin therapy for resistant inflammatory pseudotumor of the orbit. Thyroid 15:398\u2013399","journal-title":"Thyroid"},{"key":"8155_CR251","first-page":"23","volume":"25","author":"N Cassoux","year":"2002","unstructured":"Cassoux N, Goichot-Bonnat L, Karmochkine M, Georges F, Kullmann N, Lehoang P, Kazatchkine M (2002) Efficacy of intravenous immunoglobulin in the treatment of Birdshot retinochoroiditis. J Fr Ophtalmol 25:23\u201330","journal-title":"J Fr Ophtalmol"},{"key":"8155_CR252","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1359::AID-MUS26>3.0.CO;2-W","volume":"21","author":"S Shambal","year":"1998","unstructured":"Shambal S, Lindner A, Zierz S (1998) Successful treatment of orbital myositis with intravenous immunoglobulins. Muscle Nerve 21:1359\u20131360","journal-title":"Muscle Nerve"},{"key":"8155_CR253","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0002-9394(99)00029-X","volume":"127","author":"JT Rosenbaum","year":"1999","unstructured":"Rosenbaum JT, George RK, Gordon C (1999) The treatment of refractory uveitis with intravenous immunoglobulin. Am J Ophthalmol 127:545\u2013549","journal-title":"Am J Ophthalmol"},{"key":"8155_CR254","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/09273940601025966","volume":"14","author":"S Onal","year":"2006","unstructured":"Onal S, Foster CS, Ahmed AR (2006) Efficacy of intravenous immunoglobulin treatment in refractory uveitis. Ocul Immunol Inflamm 14:367\u2013374","journal-title":"Ocul Immunol Inflamm"},{"key":"8155_CR255","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/thy.1997.7.579","volume":"7","author":"L Baschieri","year":"1997","unstructured":"Baschieri L, Antonelli A, Nardi S, Alberti B, Lepri A, Canapicchi R, Fallahi P (1997) Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. Thyroid 7:579\u2013585","journal-title":"Thyroid"},{"key":"8155_CR256","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1365-2249.1996.d01-854.x","volume":"106","author":"G Kahaly","year":"1996","unstructured":"Kahaly G, Pitz S, Muller-Forell W, Hommel G (1996) Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy. Clin Exp Immunol 106:197\u2013202","journal-title":"Clin Exp Immunol"},{"key":"8155_CR257","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.117.4.471","volume":"117","author":"J Guy","year":"1999","unstructured":"Guy J, Aptsiauri N (1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 117:471\u2013477","journal-title":"Arch Ophthalmol"},{"key":"8155_CR258","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNO.0b013e31816754c4","volume":"28","author":"C Subhadra","year":"2008","unstructured":"Subhadra C, Dudek AZ, Rath PP, Lee MS (2008) Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin. J Neuroophthalmol 28:23\u201326","journal-title":"J Neuroophthalmol"},{"key":"8155_CR259","doi-asserted-by":"publisher","first-page":"c113","DOI":"10.1159\/000113528","volume":"108","author":"F Floccari","year":"2008","unstructured":"Floccari F, Cosentini V, Giacobbe M, Coppolino G, Campo S, Bolignano D, Tripodo D, Nostro L, Buemi M (2008) A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins. Nephron Clin Pract 108:c113\u2013c120","journal-title":"Nephron Clin Pract"},{"key":"8155_CR260","first-page":"98","volume":"35","author":"R Palla","year":"1991","unstructured":"Palla R, Cirami C, Panichi V, Bianchi AM, Parrini M, Grazi G (1991) Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety. Clin Nephrol 35:98\u2013104","journal-title":"Clin Nephrol"},{"key":"8155_CR261","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/ndt\/14.10.2379","volume":"14","author":"H Yokoyama","year":"1999","unstructured":"Yokoyama H, Goshima S, Wada T, Takaeda M, Furuichi K, Kobayashi K, Kida H (1999) The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Kanazawa Study Group for Renal Diseases and Hypertension. Nephrol Dial Transplant 14:2379\u20132386","journal-title":"Nephrol Dial Transplant"},{"key":"8155_CR262","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2249.2006.03189.x","volume":"146","author":"FM Rasche","year":"2006","unstructured":"Rasche FM, Keller F, Lepper PM, Aymanns C, Karges W, Sailer LC, Muller L, Czock D (2006) High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up. Clin Exp Immunol 146:47\u201353","journal-title":"Clin Exp Immunol"},{"key":"8155_CR263","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","volume":"81","author":"A Sener","year":"2006","unstructured":"Sener A, House AA, Jevnikar AM, Boudville N, McAlister VC, Muirhead N, Rehman F, Luke PP (2006) Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 81:117\u2013120","journal-title":"Transplantation"},{"key":"8155_CR264","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1399-3046.2008.00958.x","volume":"13","author":"AP Sharma","year":"2008","unstructured":"Sharma AP, Moussa M, Casier S, Rehman F, Filler G, Grimmer J (2008) Intravenous immunoglobulin as rescue therapy for BK virus nephropathy. Pediatr Transplant 13:123\u2013129","journal-title":"Pediatr Transplant"},{"key":"8155_CR265","doi-asserted-by":"publisher","first-page":"c35","DOI":"10.1159\/000088313","volume":"102","author":"T Ito-Ihara","year":"2006","unstructured":"Ito-Ihara T, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, Fukatsu A, Kita T, Suzuki K, Muso E (2006) Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis. Nephron Clin Pract 102:c35\u2013c42","journal-title":"Nephron Clin Pract"},{"key":"8155_CR266","first-page":"453","volume":"3","author":"A Basok","year":"2001","unstructured":"Basok A, Shnaider A, Tovbin D, Rogachev B (2001) Successful use of high dose intravenous immunoglobulin in rapidly progressive crescentic glomerulonephritis with vasculitis. Isr Med Assoc J 3:453\u2013454","journal-title":"Isr Med Assoc J"},{"key":"8155_CR267","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0272-6386(12)70265-2","volume":"20","author":"P Tuso","year":"1992","unstructured":"Tuso P, Moudgil A, Hay J, Goodman D, Kamil E, Koyyana R, Jordan SC (1992) Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gamma globulin. Am J Kidney Dis 20:504\u2013508","journal-title":"Am J Kidney Dis"},{"key":"8155_CR268","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/TP.0b013e3181880b35","volume":"86","author":"H Billing","year":"2008","unstructured":"Billing H, Rieger S, Ovens J, Susal C, Melk A, Waldherr R, Opelz G, Tonshoff B (2008) Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 86:1214\u20131221","journal-title":"Transplantation"},{"key":"8155_CR269","first-page":"211","volume":"6","author":"YW Yang","year":"2008","unstructured":"Yang YW, Lin WC, Wu MS, Lee PH, Tsai MK (2008) Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant. Exp Clin Transplant 6:211\u2013214","journal-title":"Exp Clin Transplant"},{"key":"8155_CR270","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1034\/j.1399-3046.1999.00022.x","volume":"3","author":"S Furth","year":"1999","unstructured":"Furth S, Neu AM, Hart J, Zachary A, Colombani P, Fivush BA (1999) Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report. Pediatr Transplant 3:146\u2013149","journal-title":"Pediatr Transplant"},{"key":"8155_CR271","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00007890-199809270-00017","volume":"66","author":"SC Jordan","year":"1998","unstructured":"Jordan SC, Quartel AW, Czer LS, Admon D, Chen G, Fishbein MC, Schwieger J, Steiner RW, Davis C, Tyan DB (1998) Posttransplant therapy using high-dose human immunoglobulin (intravenous gamma globulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66:800\u2013805","journal-title":"Transplantation"},{"key":"8155_CR272","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(99)01575-5","volume":"354","author":"JN Boletis","year":"1999","unstructured":"Boletis JN, Ioannidis JP, Boki KA, Moutsopoulos HM (1999) Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. Lancet 354:569\u2013570","journal-title":"Lancet"},{"key":"8155_CR273","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0049-0172(00)80018-9","volume":"29","author":"Y Levy","year":"2000","unstructured":"Levy Y, Sherer Y, George J, Rovensky J, Lukac J, Rauova L, Poprac P, Langevitz P, Fabbrizzi F, Shoenfeld Y (2000) Intravenous immunoglobulin treatment of lupus nephritis. Semin Arthritis Rheum 29:321\u2013327","journal-title":"Semin Arthritis Rheum"},{"key":"8155_CR274","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s002960000053","volume":"19","author":"M Meissner","year":"2000","unstructured":"Meissner M, Sherer Y, Levy Y, Chwalinska-Sadowska H, Langevitz P, Shoenfeld Y (2000) Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis. Rheumatol Int 19:199\u2013201","journal-title":"Rheumatol Int"},{"key":"8155_CR275","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s100670050060","volume":"18","author":"H Arahata","year":"1999","unstructured":"Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, Tominaga M, Origuchi T, Kawabe Y, Hida A, Taguchi T, Eguchi K (1999) Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 18:77\u201381","journal-title":"Clin Rheumatol"},{"key":"8155_CR276","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1067\/mjd.2001.116339","volume":"45","author":"A Razzaque Ahmed","year":"2001","unstructured":"Razzaque Ahmed A (2001) Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 45:679\u2013690","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR277","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1468-3083.2006.01540.x","volume":"20","author":"S Baum","year":"2006","unstructured":"Baum S, Scope A, Barzilai A et al (2006) The role of IVIG treatment in severe pemphigus vulgaris. J Eur Acad Dermatol Venereol 20:548\u2013552","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8155_CR278","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1067\/mjd.2002.122735","volume":"47","author":"JC Bystryn","year":"2002","unstructured":"Bystryn JC, Jiao D, Natow S (2002) Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermatol 47:358\u2013363","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR279","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/archderm.138.9.1158","volume":"138","author":"N Sami","year":"2002","unstructured":"Sami N, Qureshi A, Ruocco E et al (2002) Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. Arch Dermatol 138:1158\u20131162","journal-title":"Arch Dermatol"},{"key":"8155_CR280","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4065\/80.1.41","volume":"80","author":"DA Wetter","year":"2005","unstructured":"Wetter DA, Davis MD, Yiannias J et al (2005) Effectiveness of intravenous immunoglobulin therapy for skin disease other than Toxic Epidermal Necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clinic Proc 80:41\u201347","journal-title":"Mayo Clinic Proc"},{"key":"8155_CR281","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1067\/mjd.2002.116338","volume":"46","author":"A Razzaque Ahmed","year":"2002","unstructured":"Razzaque Ahmed A, Sami N (2002) Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional treatment. J Am Acad Dermatol 46:42\u201349","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR282","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1006\/clim.2002.5278","volume":"105","author":"N Sami","year":"2002","unstructured":"Sami N, Bhol KC, Razzaque Ahmed A (2002) Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus. Clin Immunol 105:192\u2013198","journal-title":"Clin Immunol"},{"key":"8155_CR283","first-page":"174","volume":"12","author":"N Sami","year":"2002","unstructured":"Sami N, Qureshi A, Razzaque Ahmed A (2002) Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus. Eur J Dermatol 12:174\u2013178","journal-title":"Eur J Dermatol"},{"key":"8155_CR284","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1067\/mjd.2001.116337","volume":"45","author":"A Razzaque Ahmed","year":"2001","unstructured":"Razzaque Ahmed A (2001) Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 45:825\u2013835","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1067\/mjd.2000.112288","volume":"44","author":"L Engineer","year":"2001","unstructured":"Engineer L, Razzaque Ahmed A (2001) Role of intravenous immunoglobulin in the treatment of bullous pemphigoid: analysis of current data. J Am Acad Dermatol 44:83\u201388","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR286","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1046\/j.1365-2249.2002.01942.x","volume":"129","author":"N Sami","year":"2002","unstructured":"Sami N, Bhol KC, Razzaque Ahmed A (2002) Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titers to human alpha6 integrin. Clin Exp Immunol 129:533\u2013540","journal-title":"Clin Exp Immunol"},{"key":"8155_CR287","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-2230.1998.00342.x","volume":"23","author":"S Hern","year":"1998","unstructured":"Hern S, Harman K, Bhogal BS et al (1998) A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulin and cyclosporin. Clin Exp Dermatol 23:185\u2013188","journal-title":"Clin Exp Dermatol"},{"key":"8155_CR288","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000070957","volume":"207","author":"C Prins","year":"2003","unstructured":"Prins C, Vittorio C, Padilla RS et al (2003) Effect of high-dose intravenous immunoglobulin therapy in Stevens\u2013Johnson syndrome: a retrospective, multicenter study. Dermatology 207:96\u201399","journal-title":"Dermatology"},{"key":"8155_CR289","first-page":"2494","volume":"27","author":"MV Morici","year":"2000","unstructured":"Morici MV, Wesley G, Shetty AK et al (2000) Intravenous immunoglobulin therapy for children with Stevens\u2013Johnson syndrome. J Rheumatol 27:2494\u20132497","journal-title":"J Rheumatol"},{"key":"8155_CR290","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-4632.2004.02048.x","volume":"43","author":"N Al-Mutairi","year":"2004","unstructured":"Al-Mutairi N, Arun J, Osama NE et al (2004) Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis. Int J Dermatol 43:847\u2013851","journal-title":"Int J Dermatol"},{"key":"8155_CR291","first-page":"430","volume":"83","author":"E Campione","year":"2003","unstructured":"Campione E, Marulli GC, Carrozzo AM et al (2003) High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis. Acta Derm Venereol 83:430\u2013432","journal-title":"Acta Derm Venereol"},{"key":"8155_CR292","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139:33\u201336","journal-title":"Arch Dermatol"},{"key":"8155_CR293","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00105-006-1104-0","volume":"57","author":"P Spornraft-Ragaller","year":"2006","unstructured":"Spornraft-Ragaller P, Theilen H, Gottschlich GS, Ragaller M (2006) Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin. Hautarzt 57:185\u2013194","journal-title":"Hautarzt"},{"key":"8155_CR294","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00000441-200502000-00007","volume":"329","author":"M Nasser","year":"2005","unstructured":"Nasser M, Bitterman-Deutsch O, Nassar F (2005) Intravenous immunoglobulin for treatment of toxic epidermal necrolysis. Am J Med Sci 329:95\u201398","journal-title":"Am J Med Sci"},{"key":"8155_CR295","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1542\/peds.112.6.1430","volume":"112","author":"D Metry","year":"2003","unstructured":"Metry D, Jung P, Levy ML (2003) Use of intravenous immunoglobulin in children with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 112:1430\u20131436","journal-title":"Pediatrics"},{"key":"8155_CR296","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archderm.139.1.26","volume":"139","author":"C Prins","year":"2003","unstructured":"Prins C, Kerdel FA, Padilla RS et al (2003) Treatment of toxic epidermal necrolysis with high dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 139:26\u201332","journal-title":"Arch Dermatol"},{"key":"8155_CR297","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archderm.139.1.39","volume":"139","author":"JT Trent","year":"2003","unstructured":"Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami Experience. Arch Dermatol 139:39\u201343","journal-title":"Arch Dermatol"},{"key":"8155_CR298","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1067\/mjd.2002.127249","volume":"47","author":"P Tristani-Firouzi","year":"2002","unstructured":"Tristani-Firouzi P, Petersen MJ, Saffle JR et al (2002) Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 47:548\u2013552","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR299","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.BCR.0000124746.33279.86","volume":"25","author":"R Shortt","year":"2004","unstructured":"Shortt R, Gomez M, Mittman N, Cartotto R (2004) Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil 25:246\u2013255","journal-title":"J Burn Care Rehabil"},{"key":"8155_CR300","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1046\/j.1365-2133.2002.04833.x","volume":"147","author":"C Paul","year":"2002","unstructured":"Paul C, Lahfa M, Bachelez H et al (2002) A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol 147:518\u2013522","journal-title":"Br J Dermatol"},{"key":"8155_CR301","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/00015550310020549","volume":"83","author":"S Jolles","year":"2003","unstructured":"Jolles S, Sewell C, Webster D et al (2003) Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. Acta Derm Venereol 83:433\u2013437","journal-title":"Acta Derm Venereol"},{"key":"8155_CR302","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-2133.2000.03377.x","volume":"142","author":"S Jolles","year":"2000","unstructured":"Jolles S, Hughes J, Rustin M (2000) The treatment of atopic dermatitis with adjunctive high dose intravenous immunoglobulin: a report of three patients and review of the literature. Br J Dermatol 142:551\u2013554","journal-title":"Br J Dermatol"},{"key":"8155_CR303","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1081-1206(10)62802-5","volume":"81","author":"M Wakim","year":"1998","unstructured":"Wakim M, Alazard M, Yajima A et al (1998) High dose immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81:153\u2013158","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8155_CR304","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.0307-6938.2001.00955.x","volume":"27","author":"S Jolles","year":"2002","unstructured":"Jolles S (2002) A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis. Clin Exp Dermatol 27:3\u20137","journal-title":"Clin Exp Dermatol"},{"key":"8155_CR305","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","volume":"138","author":"BF O'Donnell","year":"1998","unstructured":"O'Donnell BF, Barr RM, Black AK et al (1998) Intravenous immunoglobulin un autoimmune chronic urticaria. Br J Dermatol 138:101\u2013106","journal-title":"Br J Dermatol"},{"key":"8155_CR306","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/000155500750012540","volume":"80","author":"M Kroiss","year":"2000","unstructured":"Kroiss M, Vogt T, Landthaler M et al (2000) The effectiveness of low dose intravenous immunoglobulin in chronic urticaria. Acta Derm Venereol 80:225","journal-title":"Acta Derm Venereol"},{"key":"8155_CR307","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1046\/j.1365-2133.2003.05486.x","volume":"149","author":"G Dawn","year":"2003","unstructured":"Dawn G, Urcelay M, Ah-Weng A et al (2003) Effect of high-dose intravenous immunoglobulin delayed pressure urticaria. Br J Dermatol 149:836\u2013840","journal-title":"Br J Dermatol"},{"key":"8155_CR308","first-page":"831","volume":"127","author":"I Puech-Plottova","year":"2000","unstructured":"Puech-Plottova I, Michel JL, Rouchouse B et al (2000) Solar urticaria: one case treated by intravenous immunoglobulin. Ann Dermatol Venereol 127:831\u2013835","journal-title":"Ann Dermatol Venereol"},{"key":"8155_CR309","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0151-9638(04)93546-6","volume":"131","author":"S Darras","year":"2004","unstructured":"Darras S, S\u00e9grad M, Mortier L et al (2004) Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy. Ann Dermatol Venereol 131:65\u201369","journal-title":"Ann Dermatol Venereol"},{"key":"8155_CR310","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00000441-200308000-00007","volume":"326","author":"FM Orson","year":"2003","unstructured":"Orson FM (2003) Intravenous immunoglobulin therapy suppresses manifestations of the angioedema with hypereosinophilia syndrome. Am J Med Sci 326:94\u201397","journal-title":"Am J Med Sci"},{"key":"8155_CR311","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1046\/j.1365-2133.2002.04753.x","volume":"147","author":"V Gurmin","year":"2002","unstructured":"Gurmin V, Mediwake R, Fernando M et al (2002) Psoriasis: response to high-dose intravenous immunoglobulin in three patients. Br J Dermatol 147:554\u2013557","journal-title":"Br J Dermatol"},{"key":"8155_CR312","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.08217.x","volume":"157","author":"DL Cummins","year":"2007","unstructured":"Cummins DL, Anhalt GJ, Monahan T, Meyerle JH (2007) Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 157:1235\u20131239","journal-title":"Br J Dermatol"},{"key":"8155_CR313","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2165\/00044011-200626090-00007","volume":"26","author":"N Meyer","year":"2006","unstructured":"Meyer N, Ferraro V, Mignard MH et al (2006) Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: two cases and review of literature. Clin Drug Investig 26:541\u2013546","journal-title":"Clin Drug Investig"},{"key":"8155_CR314","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1365-2133.2003.05795.x","volume":"150","author":"HJ Chung","year":"2004","unstructured":"Chung HJ, Chung KY (2004) Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin. Br J Dermatol 150:596\u2013597","journal-title":"Br J Dermatol"},{"key":"8155_CR315","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/thy.1994.4.399","volume":"4","author":"A Antonelli","year":"1994","unstructured":"Antonelli A, Navarranne A, Palla R et al (1994) Pretibial myxedema and high-dose intravenous immunoglobulin treatment. Thyroid 4:399\u2013408","journal-title":"Thyroid"},{"key":"8155_CR316","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MD.0b013e3181630835","volume":"87","author":"M Blum","year":"2008","unstructured":"Blum M, Wigley FM, Hummers LK (2008) Scleromyxedema. A case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine 87:10\u201320","journal-title":"Medicine"},{"key":"8155_CR317","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1365-2133.2003.05682.x","volume":"149","author":"A Kulczycki","year":"2003","unstructured":"Kulczycki A, Nelson M, Eisen A, Heffernan M (2003) Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 149:1276\u20131281","journal-title":"Br J Dermatol"},{"key":"8155_CR318","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0190-9622(00)70305-7","volume":"43","author":"RK Lister","year":"2000","unstructured":"Lister RK, Jolles S, Whittaker S, Black C, Forgacs I, Cramp M, Potter M, Rustin MH (2000) Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 43:403\u2013408","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR319","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1365-2133.2007.08169.x","volume":"157","author":"P Gholam","year":"2007","unstructured":"Gholam P, Hartmann M, Enk A (2007) Arndt\u2013Gottron scleromyxedema: successful therapy with intravenous immunoglobulins. Br J Dermatol 157:1058\u20131060","journal-title":"Br J Dermatol"},{"key":"8155_CR320","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10227-005-0137-9","volume":"9","author":"C Majeski","year":"2005","unstructured":"Majeski C, Taher M, Grewal P et al (2005) Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema. J Cutan Med Surg 9:99\u2013104","journal-title":"J Cutan Med Surg"},{"key":"8155_CR321","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1468-3083.2006.01951.x","volume":"21","author":"A K\u00f6rber","year":"2007","unstructured":"K\u00f6rber A, Franckson T, Grabbe S, Dissemond J (2007) Successful therapy of scleromyxedema Arndt\u2013Gottron with low-dose intravenous immunoglobulin. Eur Acad Dermatol Venereol 21:553\u2013554","journal-title":"Eur Acad Dermatol Venereol"},{"key":"8155_CR322","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00105-006-1261-1","volume":"58","author":"S Topf","year":"2007","unstructured":"Topf S, Simon M, Schell H, L\u00fcftl M (2007) Marked improvement in scleromyxedema with high-dose immunoglobulin. Hautarzt 58:525\u2013528","journal-title":"Hautarzt"},{"key":"8155_CR323","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1468-3083.2005.01134.x","volume":"19","author":"A Wojas-Pelc","year":"2005","unstructured":"Wojas-Pelc A, B\u0142aszczyk M, Glinska M, Jab\u0142onska S (2005) Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. Eur Acad Dermatol Venereol 19:462\u2013465","journal-title":"Eur Acad Dermatol Venereol"},{"key":"8155_CR324","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.intimp.2005.11.017","volume":"6","author":"S Jolles","year":"2006","unstructured":"Jolles S, Hughes J (2006) Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Int Immunopharmacol 6:579\u2013591","journal-title":"Int Immunopharmacol"},{"key":"8155_CR325","first-page":"59","volume":"17","author":"S Boonyaleepun","year":"1999","unstructured":"Boonyaleepun S, Boonyaleepun C, Schlactus JL (1999) Effect of IVIG on the hair regrowth in a common variable immune deficiency patient with alopecia universalis. Asian Pac J Allergy Immunol 17:59\u201362","journal-title":"Asian Pac J Allergy Immunol"},{"key":"8155_CR326","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1002\/1097-0142(19940601)73:11<2859::AID-CNCR2820731132>3.0.CO;2-P","volume":"73","author":"Y Carmeli","year":"1994","unstructured":"Carmeli Y, Mevorach D, Kaminski N, Raz E (1994) Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer 73:2859\u20132891","journal-title":"Cancer"},{"key":"8155_CR327","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1196\/annals.1423.032","volume":"1110","author":"J Schachter","year":"2007","unstructured":"Schachter J, Katz U, Mahrer A et al (2007) Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma. Ann N Y Acad Sci 1110:305\u2013314","journal-title":"Ann N Y Acad Sci"},{"key":"8155_CR328","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/jnci\/89.4.326","volume":"89","author":"P Plevova","year":"1997","unstructured":"Plevova P, Blazek B (1997) Intravenous immunoglobulin as prophylaxis of chemotherapy-induced oral mucositis. J Natl Cancer Inst 89:326\u2013327","journal-title":"J Natl Cancer Inst"},{"key":"8155_CR329","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12094-006-0043-7","volume":"8","author":"M Murie-Fernandez","year":"2006","unstructured":"Murie-Fernandez M, Gurpide A, de la Cruz S, de Castro P (2006) Total remission of thymus carcinoma after treatment with intravenous immunoglobulin. Clin Transl Oncol 8:697\u2013699","journal-title":"Clin Transl Oncol"},{"key":"8155_CR330","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1081-1206(10)60695-3","volume":"98","author":"S Agarwal","year":"2007","unstructured":"Agarwal S, Cunningham-Rundles C (2007) Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol 98:185\u2013190","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8155_CR331","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/archneur.59.5.751","volume":"59","author":"KR Sharma","year":"2002","unstructured":"Sharma KR, Cross J, Ayyar DR et al (2002) Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 59:751\u2013757","journal-title":"Arch Neurol"},{"key":"8155_CR332","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/jnnp.2006.111302","volume":"78","author":"Y Kawagashira","year":"2007","unstructured":"Kawagashira Y, Watanabe H, Oki Y et al (2007) Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry 78:899\u2013901","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR333","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/0028-3886.27163","volume":"54","author":"D Uluduz","year":"2005","unstructured":"Uluduz D, Bozluolcay M, Ince B, Kiziltan M (2005) Simultaneous multiple cranial nerve neuropathies and intravenous immunoglobulin treatment in diabetes mellitus. Neurol India 54:308\u2013309","journal-title":"Neurol India"},{"key":"8155_CR334","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.diabres.2006.05.006","volume":"75","author":"Y Wada","year":"2007","unstructured":"Wada Y, Yanagihara C, Nishimura Y, Oka N (2007) A case of diabetic amyotrophy with severe atrophy and weakness of shoulder girdle muscles showing good response to intravenous immune globulin. Diabetes Res Clin Pract 75:107\u2013110","journal-title":"Diabetes Res Clin Pract"},{"key":"8155_CR335","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1600-6143.2005.01185.x","volume":"6","author":"M Melcher","year":"2006","unstructured":"Melcher M, Olson JL, Baxter-Lowe LA et al (2006) Antibody-mediated rejection of a pancreas allograft. Am J Transplant 6:423\u2013428","journal-title":"Am J Transplant"},{"key":"8155_CR336","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.nmd.2005.01.008","volume":"15","author":"R Reisin","year":"2005","unstructured":"Reisin R, Zurr\u00fa C, Buso C et al (2005) Multifocal motor neuropath, type 1 diabetes and asymptomatic Hashimoto's thyroiditis: an unusual association. Neuromuscul Disord 15:358\u2013360","journal-title":"Neuromuscul Disord"},{"key":"8155_CR337","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0960-8966(01)00311-X","volume":"12","author":"A Toscano","year":"2002","unstructured":"Toscano A, Rodolico C, Benvenga S et al (2002) Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of association. Neuromuscul Disord 12:566\u2013568","journal-title":"Neuromuscul Disord"},{"key":"8155_CR338","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.clineuro.2007.02.006","volume":"109","author":"N Yuceyar","year":"2007","unstructured":"Yuceyar N, Karadeniz M, Erdogan M et al (2007) Thyrotoxic autoimmune encephalopathy in a female patient: only partial response to typical immunosuppressant treatment and remission after thyroidectomy. Clin Neurol Neurosurg 109:458\u2013462","journal-title":"Clin Neurol Neurosurg"},{"issue":"Supplement","key":"8155_CR339","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/jnnp.57.Suppl.69","volume":"57","author":"M Cappa","year":"1994","unstructured":"Cappa M, Bertini E, Del Balzo P et al (1994) High dose immunoglobulin IV treatment in adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 57(Supplement):69\u201370","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl","key":"8155_CR340","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/jnnp.57.Suppl.71","volume":"57","author":"W Kohler","year":"1994","unstructured":"Kohler W (1994) Discussion on: high dose immunoglobulin IV treatment in adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 57(Suppl):71","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR341","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/ajkd.2000.8994","volume":"36","author":"M Agraharkar","year":"2000","unstructured":"Agraharkar M, Fahlen M, Siddiqui M et al (2000) Waterhouse\u2013Friderichsen syndrome and bilateral renal cortical necrosis in meningococcal sepsis. Am J Kidney Disease 36:396\u2013400","journal-title":"Am J Kidney Disease"},{"key":"8155_CR342","first-page":"43","volume":"141","author":"A Antonelli","year":"1992","unstructured":"Antonelli A, Gambuzza C, Alberti B et al (1992) Autoimmune polyendocrine syndrome. Treatment with intravenous immunoglobulins. Clin Ther 141:43\u201348","journal-title":"Clin Ther"},{"key":"8155_CR343","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pediatrneurol.2008.05.015","volume":"39","author":"WG Leen","year":"2008","unstructured":"Leen WG, Weemaes CM, Verbeek MM, Willemsen MA, Rotteveel JJ (2008) Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome. Pediatr Neurol 39:213\u2013217","journal-title":"Pediatr Neurol"},{"key":"8155_CR344","first-page":"520","volume":"52","author":"A Unal","year":"2004","unstructured":"Unal A, Sumer MM, Atasoy HT, Atasoy N (2004) Treatment of idiopathic opsoclonus-myoclonus syndrome with intravenous immunoglobulin. Neurol India 52:520\u2013521","journal-title":"Neurol India"},{"key":"8155_CR345","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/jnnp.74.2.279","volume":"74","author":"K Glatz","year":"2003","unstructured":"Glatz K, Meinck HM, Wildemann B (2003) Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective. J Neurol Neurosurg Psychiatry 74:279\u2013280","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR346","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/mds.10283","volume":"17","author":"MR Pranzatelli","year":"2002","unstructured":"Pranzatelli MR, Tate ED, Kinsbourne M, Caviness VS Jr, Mishra B (2002) Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG. Mov Disord 17:1387\u20131390","journal-title":"Mov Disord"},{"key":"8155_CR347","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3476(96)70225-1","volume":"129","author":"C Borgna-Pignatti","year":"1996","unstructured":"Borgna-Pignatti C, Balter R, Marradi P, Colamaria V (1996) Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus. J Pediatr 129:179\u2013180","journal-title":"J Pediatr"},{"key":"8155_CR348","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.46.2.583-a","volume":"46","author":"M Pless","year":"1996","unstructured":"Pless M, Ronthal M (1996) Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Neurology 46:583\u2013584","journal-title":"Neurology"},{"key":"8155_CR349","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0022-3476(95)70322-5","volume":"127","author":"MJ Petruzzi","year":"1995","unstructured":"Petruzzi MJ, de Alarcon PA (1995) Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G. J Pediatr 127:328\u2013329","journal-title":"J Pediatr"},{"key":"8155_CR350","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1651-2227.1992.tb12248.x","volume":"81","author":"H Sugie","year":"1992","unstructured":"Sugie H, Sugie Y, Akimoto H, Endo K, Shirai M, Ito M (1992) High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome. Acta Paediatr 81:371\u2013372","journal-title":"Acta Paediatr"},{"key":"8155_CR351","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124:437\u2013443","journal-title":"Brain"},{"key":"8155_CR352","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","volume":"354","author":"SJ Perlmutter","year":"1999","unstructured":"Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153\u20131158","journal-title":"Lancet"},{"key":"8155_CR353","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000318281.98220.6f","volume":"71","author":"F Fazekas","year":"2008","unstructured":"Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sorensen PS, Maas-Enriquez M, Sommerauer B, Hanna K (2008) Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology 71:265\u2013271","journal-title":"Neurology"},{"key":"8155_CR354","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/1352458507078400","volume":"13","author":"D Pohlau","year":"2007","unstructured":"Pohlau D, Przuntek H, Sailer M, Bethke F, Koehler J, Konig N, Heesen C, Spath P, Andresen I (2007) Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study. Mult Scler 13:1107\u20131117","journal-title":"Mult Scler"},{"key":"8155_CR355","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1191\/135248506ms1246oa","volume":"12","author":"HF Petereit","year":"2006","unstructured":"Petereit HF, Reske D, Pukrop R, Maas-Enriquez M, Japp G, Jongen PJ, Kolmel HW, Merkelbach S, Hartung HP, Heiss WD, Hommes OR (2006) No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosis. Mult Scler 12:66\u201371","journal-title":"Mult Scler"},{"key":"8155_CR356","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1191\/1352458505ms1224oa","volume":"11","author":"J Haas","year":"2005","unstructured":"Haas J, Maas-Enriquez M, Hartung HP (2005) Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis\u2014results of a retrospective multicenter observational study over five years. Mult Scler 11:562\u2013567","journal-title":"Mult Scler"},{"key":"8155_CR357","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(04)17101-8","volume":"364","author":"OR Hommes","year":"2004","unstructured":"Hommes OR, Sorensen PS, Fazekas F, Enriquez MM, Koelmel HW, Fernandez O, Pozzilli C, O'Connor P (2004) Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. Lancet 364:1149\u20131156","journal-title":"Lancet"},{"key":"8155_CR358","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1046\/j.1468-1331.2002.00501.x","volume":"9","author":"PS Sorensen","year":"2002","unstructured":"Sorensen PS, Fazekas F, Lee M (2002) Intravenous immunoglobulin G for the treatment of relapsing\u2013remitting multiple sclerosis: a meta-analysis. Eur J Neurol 9:557\u2013563","journal-title":"Eur J Neurol"},{"key":"8155_CR359","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s001150050284","volume":"69","author":"F Fazekas","year":"1998","unstructured":"Fazekas F, Strasser-Fuchs S, Hartung HP (1998) Intravenous immunoglobulins in therapy of intermittent multiple sclerosis. An update. Nervenarzt 69:361\u2013365","journal-title":"Nervenarzt"},{"key":"8155_CR360","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/WNL.50.2.398","volume":"50","author":"A Achiron","year":"1998","unstructured":"Achiron A, Gabbay U, Gilad R, Hassin-Baer S, Barak Y, Gornish M, Elizur A, Goldhammer Y, Sarova-Pinhas I (1998) Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 50:398\u2013402","journal-title":"Neurology"},{"key":"8155_CR361","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/135245859700300216","volume":"3","author":"PS Sorensen","year":"1997","unstructured":"Sorensen PS, Wanscher B, Schreiber K, Blinkenberg M, Jensen CV, Ravnborg M (1997) A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: preliminary results. Mult Scler 3:145\u2013148","journal-title":"Mult Scler"},{"key":"8155_CR362","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA (2007) Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review. Brain 130:2245\u20132257","journal-title":"Brain"},{"key":"8155_CR363","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1442-200X.2003.01768.x","volume":"45","author":"J Yata","year":"2003","unstructured":"Yata J, Nihei K, Ohya T, Hirano Y, Momoi M, Maekawa K, Sakakihara Y (2003) High-dose immunoglobulin therapy for Guillain\u2013Barr\u00e9 syndrome in Japanese children. Pediatr Int 45:543\u2013549","journal-title":"Pediatr Int"},{"key":"8155_CR364","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/jnnp.71.2.235","volume":"71","author":"JC Raphael","year":"2001","unstructured":"Raphael JC, Chevret S, Harboun M, Jars-Guincestre MC (2001) Intravenous immune globulins in patients with Guillain\u2013Barr\u00e9 syndrome and contraindications to plasma exchange: 3\u00a0days versus 6\u00a0days. J Neurol Neurosurg Psychiatry 71:235\u2013238","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR365","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/1097-4598(200101)24:1<54::AID-MUS6>3.0.CO;2-9","volume":"24","author":"S Kuwabara","year":"2001","unstructured":"Kuwabara S, Mori M, Ogawara K, Hattori T, Oda S, Koga M, Yuki N (2001) Intravenous immunoglobulin therapy for Guillain\u2013Barr\u00e9 syndrome with IgG anti-GM1 antibody. Muscle Nerve 24:54\u201358","journal-title":"Muscle Nerve"},{"key":"8155_CR366","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group","year":"1997","unstructured":"Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain\u2013Barr\u00e9 syndrome. Lancet 349:225\u2013230","journal-title":"Lancet"},{"issue":"Suppl 1","key":"8155_CR367","first-page":"43","volume":"97","author":"FG van der Meche","year":"1994","unstructured":"van der Meche FG (1994) Intravenous immune globulin in the Guillain\u2013Barr\u00e9 syndrome. Clin Exp Immunol 97(Suppl 1):43\u201347","journal-title":"Clin Exp Immunol"},{"key":"8155_CR368","first-page":"CD002827","volume":"2","author":"MP Lunn","year":"2006","unstructured":"Lunn MP, Nobile-Orazio E (2006) Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 2:CD002827","journal-title":"Cochrane Database Syst Rev"},{"key":"8155_CR369","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","volume":"249","author":"G Comi","year":"2002","unstructured":"Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I, Karageorgiou C, Nobile-Orazio E, van den Bergh P, Swan T, Hughes R, Aubry J, Baumann N, Hadden R, Lunn M, Knapp M, Leger JM, Bouche P, Mazanec R, Meucci N, van der Meche F, Toyka K (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 249:1370\u20131377","journal-title":"J Neurol"},{"key":"8155_CR370","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ana.410400516","volume":"40","author":"MC Dalakas","year":"1996","unstructured":"Dalakas MC, Quarles RH, Farrer RG, Dambrosia J, Soueidan S, Stein DP, Cupler E, Sekul EA, Otero C (1996) A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 40:792\u2013795","journal-title":"Ann Neurol"},{"key":"8155_CR371","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02444000","volume":"243","author":"N Meucci","year":"1996","unstructured":"Meucci N, Nobile-Orazio E, Scarlato G (1996) Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J Neurol 243:117\u2013120","journal-title":"J Neurol"},{"key":"8155_CR372","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archneur.1994.00540210031010","volume":"51","author":"MC Dalakas","year":"1994","unstructured":"Dalakas MC, Stein DP, Otero C, Sekul E, Cupler EJ, McCrosky S (1994) Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch Neurol 51:861\u2013864","journal-title":"Arch Neurol"},{"key":"8155_CR373","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","volume":"47","author":"PG Bain","year":"1996","unstructured":"Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, Vincent A, Lang B (1996) Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome. Neurology 47:678\u2013683","journal-title":"Neurology"},{"key":"8155_CR374","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.1780370621","volume":"37","author":"EW Karlson","year":"1994","unstructured":"Karlson EW, Sudarsky L, Ruderman E, Pierson S, Scott M, Helfgott SM (1994) Treatment of stiff-man syndrome with intravenous immune globulin. Arthritis Rheum 37:915\u2013918","journal-title":"Arthritis Rheum"},{"key":"8155_CR375","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.44.9.1652","volume":"44","author":"AA Amato","year":"1994","unstructured":"Amato AA, Cornman EW, Kissel JT (1994) Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology 44:1652\u20131654","journal-title":"Neurology"},{"key":"8155_CR376","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.4065\/74.12.1231","volume":"74","author":"H Khanlou","year":"1999","unstructured":"Khanlou H, Eiger G (1999) Long-term remission of refractory stiff-man syndrome after treatment with intravenous immunoglobulin. Mayo Clin Proc 74:1231\u20131232","journal-title":"Mayo Clin Proc"},{"key":"8155_CR377","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa01167","volume":"345","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B (2001) High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 345:1870\u20131876","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"8155_CR378","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/jnnp.57.Suppl.69","volume":"57","author":"M Cappa","year":"1994","unstructured":"Cappa M, Bertini E, del Balzo P, Cambiaso P, Di Biase A, Salvati S (1994) High dose immunoglobulin IV treatment in adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 57(Suppl):69\u201370 discussion 71","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR379","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF02592447","volume":"24","author":"K van Rijckevorsel-Harmant","year":"1994","unstructured":"van Rijckevorsel-Harmant K, Delire M, Schmitz-Moorman W, Wieser HG (1994) Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind\/dose finding clinical study. Int J Clin Lab Res 24:162\u2013166","journal-title":"Int J Clin Lab Res"},{"key":"8155_CR380","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-2008-1071468","volume":"21","author":"N Illum","year":"1990","unstructured":"Illum N, Taudorf K, Heilmann C, Smith T, Wulff K, Mansa B, Platz P (1990) Intravenous immunoglobulin: a single-blind trial in children with Lennox\u2013Gastaut syndrome. Neuropediatrics 21:87\u201390","journal-title":"Neuropediatrics"},{"key":"8155_CR381","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s001340050471","volume":"23","author":"M Mohr","year":"1997","unstructured":"Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23:1144\u20131149","journal-title":"Intensive Care Med"},{"key":"8155_CR382","first-page":"1494","volume":"17","author":"EF Wijdicks","year":"1994","unstructured":"Wijdicks EF, Fulgham JR (1994) Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle Nerve 17:1494\u20131495","journal-title":"Muscle Nerve"},{"key":"8155_CR383","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1212\/01.WNL.0000099074.04539.E0","volume":"61","author":"T Granata","year":"2003","unstructured":"Granata T, Fusco L, Gobbi G, Freri E, Ragona F, Broggi G, Mantegazza R, Giordano L, Villani F, Capovilla G, Vigevano F, Bernardina BD, Spreafico R, Antozzi C (2003) Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 61:1807\u20131810","journal-title":"Neurology"},{"key":"8155_CR384","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1212\/WNL.56.2.248","volume":"56","author":"F Villani","year":"2001","unstructured":"Villani F, Spreafico R, Farina L, Giovagnoli AR, Bernasconi P, Granata T, Avanzini G (2001) Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 56:248\u2013250","journal-title":"Neurology"},{"key":"8155_CR385","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/WNL.52.4.738","volume":"52","author":"JP Leach","year":"1999","unstructured":"Leach JP, Chadwick DW, Miles JB, Hart IK (1999) Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology 52:738\u2013742","journal-title":"Neurology"},{"key":"8155_CR386","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/WNL.44.6.1030","volume":"44","author":"YM Hart","year":"1994","unstructured":"Hart YM, Cortez M, Andermann F, Hwang P, Fish DR, Dulac O, Silver K, Fejerman N, Cross H, Sherwin A et al (1994) Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 44:1030\u20131036","journal-title":"Neurology"},{"key":"8155_CR387","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","volume":"7","author":"RA Hughes","year":"2008","unstructured":"Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA (2008) Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 7:136\u2013144","journal-title":"Lancet Neurol"},{"key":"8155_CR388","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"R Hughes","year":"2001","unstructured":"Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195\u2013201","journal-title":"Ann Neurol"},{"key":"8155_CR389","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","volume":"56","author":"JR Mendell","year":"2001","unstructured":"Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ (2001) Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 56:445\u2013449","journal-title":"Neurology"},{"issue":"Pt 4","key":"8155_CR390","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Zochodne D, Feasby TE (1996) Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 119(Pt 4):1067\u20131077","journal-title":"Brain"},{"key":"8155_CR391","first-page":"CD002277","volume":"2","author":"P Gajdos","year":"2008","unstructured":"Gajdos P, Chevret S, Toyka K (2008) Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 2:CD002277","journal-title":"Cochrane Database Syst Rev"},{"key":"8155_CR392","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","volume":"68","author":"L Zinman","year":"2007","unstructured":"Zinman L, Ng E, Bril V (2007) IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial. Neurology 68:837\u2013841","journal-title":"Neurology"},{"key":"8155_CR393","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mus.10224","volume":"26","author":"GI Wolfe","year":"2002","unstructured":"Wolfe GI, Barohn RJ, Foster BM, Jackson CE, Kissel JT, Day JW, Thornton CA, Nations SP, Bryan WW, Amato AA, Freimer ML, Parry GJ (2002) Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve 26:549\u2013552","journal-title":"Muscle Nerve"},{"key":"8155_CR394","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1046\/j.1525-1594.2001.06717.x","volume":"25","author":"J Ronager","year":"2001","unstructured":"Ronager J, Ravnborg M, Hermansen I, Vorstrup S (2001) Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. Artif Organs 25:967\u2013973","journal-title":"Artif Organs"},{"key":"8155_CR395","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<551::AID-MUS14>3.0.CO;2-O","volume":"23","author":"A Achiron","year":"2000","unstructured":"Achiron A, Barak Y, Miron S, Sarova-Pinhas I (2000) Immunoglobulin treatment in refractory myasthenia gravis. Muscle Nerve 23:551\u2013555","journal-title":"Muscle Nerve"},{"key":"8155_CR396","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/01.wnl.0000318277.25679.9e","volume":"71","author":"DC Fu","year":"2008","unstructured":"Fu DC, Montgomery JR (2008) High-dose, rapid-infusion IVIG in postvaccination acute disseminated encephalomyelitis. Neurology 71:294\u2013295","journal-title":"Neurology"},{"key":"8155_CR397","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/08830738020170111001","volume":"17","author":"E Shahar","year":"2002","unstructured":"Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N (2002) Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol 17:810\u2013814","journal-title":"J Child Neurol"},{"key":"8155_CR398","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/PL00007836","volume":"249","author":"E Marchioni","year":"2002","unstructured":"Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D, PiccoloG IF, Romani A, Ceroni M (2002) Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 249:100\u2013104","journal-title":"J Neurol"},{"key":"8155_CR399","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0887-8994(00)00229-0","volume":"24","author":"R Straussberg","year":"2001","unstructured":"Straussberg R, Schonfeld T, Weitz R, Karmazyn B, Harel L (2001) Improvement of atypical acute disseminated encephalomyelitis with steroids and intravenous immunoglobulins. Pediatr Neurol 24:139\u2013143","journal-title":"Pediatr Neurol"},{"key":"8155_CR400","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1017\/S0012162201220258","volume":"43","author":"JB Andersen","year":"2001","unstructured":"Andersen JB, Rasmussen LH, Herning M, Paerregaard A (2001) Dramatic improvement of severe acute disseminated encephalomyelitis after treatment with intravenous immunoglobulin in a three-year-old boy. Dev Med Child Neurol 43:136\u2013138","journal-title":"Dev Med Child Neurol"},{"key":"8155_CR401","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.54.6.1370","volume":"54","author":"DJ Sahlas","year":"2000","unstructured":"Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 54:1370\u20131372","journal-title":"Neurology"},{"key":"8155_CR402","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/A:1023096728131","volume":"29","author":"G DelGiudice-Asch","year":"1999","unstructured":"DelGiudice-Asch G, Simon L, Schmeidler J, Cunningham-Rundles C, Hollander E (1999) Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism. J Autism Dev Disord 29:157\u2013160","journal-title":"J Autism Dev Disord"},{"key":"8155_CR403","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","volume":"134","author":"P Quartier","year":"1999","unstructured":"Quartier P, Debre M, de Blic J et al (1999) Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 134:589\u2013596","journal-title":"J Pediatr"},{"key":"8155_CR404","first-page":"335","volume":"146","author":"JG Liese","year":"1992","unstructured":"Liese JG, Wintergerst U, Tympner KD, Belohradsky BH (1992) High- vs. low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am J Dis Child 146:335\u2013339","journal-title":"Am J Dis Child"},{"key":"8155_CR405","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0928-8244(03)00304-3","volume":"40","author":"A Aghamohammadi","year":"2004","unstructured":"Aghamohammadi A, Moin M, Farhoudi A et al (2004) Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Med Microbiol 40:113\u2013118","journal-title":"FEMS Immunol Med Microbiol"},{"key":"8155_CR406","first-page":"237","volume":"36","author":"MT Nolte","year":"1979","unstructured":"Nolte MT, Pirofsky B, Gerritz GA, Golding B (1979) Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol 36:237\u2013243","journal-title":"Clin Exp Immunol"},{"key":"8155_CR407","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","volume":"135","author":"HW Eijkhout","year":"2001","unstructured":"Eijkhout HW, van der Meer JWM, Kallenberg CGM et al (2001) The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann Int Med 135:165\u2013174","journal-title":"Ann Int Med"},{"key":"8155_CR408","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/adc.75.5.436","volume":"75","author":"J Litzman","year":"1996","unstructured":"Litzman J, Jones A, Hann I et al (1996) Intravenous immunoglobulin, splenectomy and antibiotic prophylaxis in Wiscott\u2013Aldrich syndrome. Arch Dis Child 75:436\u2013439","journal-title":"Arch Dis Child"},{"key":"8155_CR409","first-page":"138","volume":"101","author":"N Matamoros Flori","year":"1993","unstructured":"Matamoros Flori N, Mila Llambi J, Hernandez Gonzalez M, Julia Benique MR (1993) New diagnostic and therapeutic aspects of hyper-IgE syndrome. Report of 3 cases. Med Clin (Barc) 101:138\u2013140","journal-title":"Med Clin (Barc)"},{"key":"8155_CR410","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jaad.2005.10.022","volume":"54","author":"CA DeWitt","year":"2006","unstructured":"DeWitt CA, Bishop AB, Buescher LS, Stone SP (2006) Hyperimmunoglobulin E syndrome: two cases and a review of the literature. J Am Acad Dermatol 54:855\u2013865","journal-title":"J Am Acad Dermatol"},{"key":"8155_CR411","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1081-1206(10)62802-5","volume":"81","author":"M Wakim","year":"1998","unstructured":"Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm ER (1998) High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81:153\u2013158","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8155_CR412","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0140-6736(92)91769-5","volume":"340","author":"JP Shield","year":"1992","unstructured":"Shield JP, Strobel S, Levinsky RJ, Morgan G (1992) Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet 340:448\u2013450","journal-title":"Lancet"},{"key":"8155_CR413","first-page":"133","volume":"121","author":"M Grob","year":"1991","unstructured":"Grob M, Joller-Jemelka HI, Grob PJ (1991) Deficiency in immunoglobulin subclasses as cause of increased infection susceptibility\u2014a family study. Schweiz Med Wochenschr 121:133\u2013144","journal-title":"Schweiz Med Wochenschr"},{"issue":"Suppl 8","key":"8155_CR414","first-page":"S251","volume":"88","author":"S Chinratanapisit","year":"2005","unstructured":"Chinratanapisit S, Tunsuriyawong P, Vichyanond P, Visitsunthorn N, Luangwedchakarn V, Jirapongsananuruk O (2005) Chronic rhinosinusitis and recurrent nasal polyps in two children with IgG subclass deficiency and review of the literature. J Med Assoc Thai 88(Suppl 8):S251\u2013S258","journal-title":"J Med Assoc Thai"},{"key":"8155_CR415","first-page":"686","volume":"86","author":"R Nettagul","year":"2003","unstructured":"Nettagul R, Visitsunthorn N, Vichyanond P (2003) A case of IgG subclass deficiency with the initial presentation of transient hypogamma immunoglobulinemia of infancy and a review of IgG subclass deficiencies. J Med Assoc Thai 86:686\u2013692","journal-title":"J Med Assoc Thai"},{"key":"8155_CR416","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1079-2104(05)80122-2","volume":"79","author":"U Nordin","year":"1995","unstructured":"Nordin U, Wannfors K, Colque-Navarro P, Mollby R, Heimdahl A (1995) Antibody response in patients with osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:429\u2013435","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"8155_CR417","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S1081-1206(10)60794-6","volume":"97","author":"YK Cheng","year":"2006","unstructured":"Cheng YK, Decker PA, O'Byrne MM, Weiler CR (2006) Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol 97:306\u2013311","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8155_CR418","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10545-005-5515-3","volume":"28","author":"D Babovic-Vuksanovic","year":"2005","unstructured":"Babovic-Vuksanovic D, Jacobson RM, Lindor NM, Weiler CR (2005) Selective antibody immune deficiency in a patient with Smith\u2013Lemli\u2013Opitz syndrome. J Inherit Metab Dis 28:181\u2013186","journal-title":"J Inherit Metab Dis"},{"key":"8155_CR419","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","volume":"110","author":"P Quartier","year":"2004","unstructured":"Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, Litzman J, Levy J, Fermand JP, Lane P, Horneff G, Aksu G, Yalcin I, Davies G, Tezcan I, Ersoy F, Catalan N, Imai K, Fischer A, Durandy A (2004) Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 110:22\u201329","journal-title":"Clin Immunol"},{"key":"8155_CR420","first-page":"544","volume":"32","author":"M Bejaoui","year":"2003","unstructured":"Bejaoui M, Mellouli F, Chouanine R, Dellagi K, Barbouche MR (2003) The hyper-IgM syndrome: 13 observations. Presse Med 32:544\u2013549","journal-title":"Presse Med"},{"key":"8155_CR421","first-page":"203","volume":"34","author":"F Ersoy","year":"1992","unstructured":"Ersoy F, Tezcan I, Sanal O (1992) Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases. Turk J Pediatr 34:203\u2013209","journal-title":"Turk J Pediatr"},{"key":"8155_CR422","first-page":"375","volume":"10","author":"A Quezada","year":"2000","unstructured":"Quezada A, Norambuena X, Gonzalez R, Ramos SM, Chavez A, Gonzalez S (2000) Non-X-linked hyperimmunoglobulin M syndrome with chronic interstitial pneumonitis. J Investig Allergol Clin Immunol 10:375\u2013379","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8155_CR423","first-page":"37","volume":"6","author":"L Atarod","year":"2007","unstructured":"Atarod L, Aghamohammadi A, Moin M, Kanegane H, Rezaei N, Rezaei Kalantari K, Amirzagar AA, Futatani T, Miyawaki M (2007) Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy. Iran J Allergy Asthma Immunol 6:37\u201340","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"8155_CR424","first-page":"334","volume":"45","author":"YC Ma","year":"2004","unstructured":"Ma YC, Shyur SD, Huang LH, Wu JY, Lin SC (2004) Hyper-IgM syndrome: report of one case. Acta Paediatr Taiwan 45:334\u2013339","journal-title":"Acta Paediatr Taiwan"},{"key":"8155_CR425","first-page":"141","volume":"38","author":"KC Hsueh","year":"2005","unstructured":"Hsueh KC, Chiu HH, Lin HC, Hsu CH, Tsai FJ (2005) Transient hypogammaglobulinemia of infancy presenting as Staphylococcus aureus sepsis with deep neck infection. J Microbiol Immunol Infect 38:141\u2013144","journal-title":"J Microbiol Immunol Infect"},{"key":"8155_CR426","first-page":"393","volume":"22","author":"A Benderly","year":"1986","unstructured":"Benderly A, Pollack S, Etzioni A (1986) Transient hypogammaglobulinemia of infancy with severe bacterial infections and persistent IgA deficiency. Isr J Med Sci 22:393\u2013396","journal-title":"Isr J Med Sci"},{"key":"8155_CR427","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM199902183400703","volume":"340","author":"RH Buckley","year":"1999","unstructured":"Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE (1999) Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340:508\u2013516","journal-title":"N Engl J Med"},{"key":"8155_CR428","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1067\/mai.2002.124999","volume":"109","author":"PJ Busse","year":"2002","unstructured":"Busse PJ, Razvi S, Cunningham-Rundles C (2002) Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109:1001\u20131004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8155-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-009-8155-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8155-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8155-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:53:50Z","timestamp":1744059230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-009-8155-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,10]]},"references-count":428,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["8155"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8155-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,10]]},"assertion":[{"value":"10 July 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}